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ABSTRACT 
Mechanosensation is an integral property of sensory systems like audition and 
somatosensation. The molecular determinants of mechanotransduction in mammals are 
only beginning to be understood. In 2010, Piezo2, a member of the Piezo family, was 
identified as the bona fide mechanotransducer in the somatosensory system of mice. 
Since then Piezo2 has been implicated in light touch, proprioception, mechanical 
allodynia and hyperalgesia. In order to understand more about the function of Piezo 
channels and their role in mechanosensation, an understanding of its regulators is vital. 
Protein-protein interactions are the bedrock of ion channel regulation and in the context 
of Piezo2, few such interactions (Stoml3 and Runx1) have been described. Recently it 
has also been found that the activity of Piezo2 is linked strongly to the properties of the 
cellular membrane. Depletion of cholesterol, mediated by Piezo2 interactor Stoml3, was 
shown to potentiate Piezo2 mediated currents. Furthermore, TRPV1 mediated 
modulation of Piezo2 was shown to involve membrane phospholipid PI(4,5)P2.  
In 2016, our lab reported the first systematic characterization of the Piezo2 interactors in 
somatosensory neurons of mice. Through a mass-spectrometry based interactomics 
approach, 36 proteins were identified as potential Piezo2 interactors. Within these 
proteins we found some known modulators of somatosensory mechanotransduction 
including Kv1.1 and CamKII. Besides these, there were some proteins which presented 
as highly unlikely interactors of Piezo2, such as Pericentrin (Pcnt). Other proteins 
identified in the screen were involved in cellular processes like protein localization, 
protein phosphorylation and vesicle mediated transport.    
In the current study, I describe the characterization of two of the Piezo2 interactors 
identified in the mass-spectrometry screen. The first part of the results describes 
Pericentrin (Pcnt) as a low probability interactor of Piezo2. The results show that Pcnt is 
expressed in close proximity with Piezo2 in both peripheral endings and cell bodies of 
DRG neurons. Additionally, Pcnt is shown to functionally modulate Piezo2 in DRG 
neurons. Loss of Pcnt in these neurons was found to potentiate Piezo2 currents and 
increase Piezo2 membrane expression. Though the mechanism of Piezo2-Pcnt 
interaction remains to be explored, the results do provide validation of the interactomics 
screen. The fact that the screen can successfully identify bona fide Piezo2 interactors 
makes it a useful resource for understanding Piezo2 function.  
The second part of the results aims to characterize the interaction between Piezo2 and 
Mtmr2. Mtmr2, is a member of the myotubularin phosphatase family which is involved in 
the phospholipid synthesis pathway. It was identified as a high probability interactor of 
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Piezo2, and notably, two other members of the same family, Mtmr1 and Mtmr5 (Sbf2) 
were also identified in the screen. The results presented here suggest that Mtmr2 is 
involved in a bi-directional regulation of Piezo2 function in DRG neurons i.e. loss of 
Mtmr2 potentiates Piezo2 mediated currents and overexpression of Mtmr2 suppresses 
Piezo2 currents. Furthermore, the phosphatase activity of Mtmr2 was found to be 
indispensable for its regulation of Piezo2. Pharmacological modulations of the 
phospholipid pathway show that PI(3,5)P2 plays a crucial role in the regulation of Piezo2. 
Further evidence for phospholipid interaction with Piezo2 came with the identification of a 
peptide segment of Piezo2 that can bind to PI(3,5)P2. Additionally, modulation of Piezo2 
by osmotic stress is shown to rely on PI(3,5)P2 levels and Mtmr2 activity. The results 
presented here provide additional evidence for regulation of Piezo2 by membrane lipids 
and how proteins regulating these lipids are relevant to Piezo2 physiology.  
In summary, since the identification of Piezo2, a quest to learn about its function and 
regulation has been underway. The results of this study combined with the interactomics 
screen published in 2016 have attempted to answer some fundamental questions about 
Piezo2 physiology. A characterization of the other proteins identified in our screen will 
help reveal more facets of Piezo2 regulation. Future studies will also add to structural 
information on Piezo2 which can further help elucidate its role as the bona fide 
mechanotransducer of the mammalian somatosensory system. 
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1. INTRODUCTION 
1.1 Somatosensation and mechanotransduction 
1.1.1 Somatosensory system 
All organisms are constantly exposed to a wide range of stimuli, the processing of which 
is crucial to their behavior. Sensory systems have evolved to detect and process these 
different stimuli thus allowing for a functional representation of the world. The 
somatosensory system has evolved to detect mechanical, chemical and thermal noxious 
and innocuous cues from the external environment and from within the body. What is 
remarkable is the ability of this system to process a wide range of stimuli from the 
stroking of a mild feather to a strong and unpleasant hit from a hammer. Unlike other 
sensory systems, somatosensation lacks a defined sensory organ but rather receives its 
information from skin, viscera and other sensory organs including the tongue, nose etc. In 
vertebrates, the cell bodies of somatosensory neurons reside in the dorsal root ganglia 
(DRGs) and the trigeminal ganglia (TGs). These neurons are pseudo unipolar which 
project one axonal branch to the periphery (for example to the skin) and the other branch 
to the dorsal horn of the spinal cord where they synapse with second order neurons. 
Because of the importance of injury and immediate repair to an organism’s survival, a 
large proportion of DRG neurons are tuned to detect noxious stimuli. These constitute the 
high threshold mechanoreceptors (HTMRs), while innocuous mechanical stimuli are 
detected by the low threshold mechanoreceptors (LTMRs). The nerve fibers belonging to 
these mechanoreceptors can be classified as Aβ, Aδ and C-fibers, based on their 
conduction velocities. At the level of the spinal cord, information travels through two 
pathways; innocuous stimulus information travels through the dorsal column medial 
lemniscus pathway up to the medial lemniscus where it decussates to the contralateral 
side and synapses in the thalamus. The noxious stimulus on the other hand decussates 
to the contralateral side at the spinal cord level and goes through the spino-thalamic 
track/anterolateral tract also synapsing in the thalamus. All the information culminates in 
the primary somatosensory cortex. This information may integrate with signals from the 
other brain areas to generate the final percept (Figure 1) (Abraira and Ginty, 2013; 
Chalfie, 2009; Kandel et al., 2000; Zhao et al., 2016).   
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1.1.2 Mechanotransduction  
Mechanotransduction is the process of converting mechanical stimuli to biologically 
relevant signals. It is a fundamental requirement for many biological processes including 
but not limited to respiration, kidney function, circulation and somatosensation (Delmas et 
al., 2011). Earliest evidence of mechanosensation in evolution can already be seen in 
archaea and eukarya, highlighting the importance of this process. In these early 
organisms, mechanotransduction played a role in cell protection and survival. As we look 
through evolution, mechanotransduction is a defining property of touch receptors in 
worms, bristle receptors in flies and auditory and skin mechanoreceptors in vertebrates 
(Delmas et al., 2011; Gillespie and Walker, 2001). But in addition to these specialized 
sensory cells, every cell may be capable of sensing mechanical stress through changes 
at single protein level or conformational changes in protein complexes. These 
mechanosensitive complexes are essential for the cells to incorporate information about 
shear stress, tension and compression and respond appropriately to these cues (Delmas 
and Coste, 2013). In the context of vertebrate sensory mechanotransduction, the 
mechanoreceptor can respond to touch or the high frequency deflections of hair cells. An 
Figure 1: Schematic illustration of mammalian somatosensory pathway  
The dorsal-column medial lemniscus pathway (left) carries information of innocuous mechanical stimuli while 
the spinothalamic tract (right) carries nociceptive or noxious stimulus information. Both tracts synapse in the 
thalamus and project to the primary somatosensory cortex. Adapted from Kandel et al. (2000). 
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essential feature of this neurosensory mechanotransduction is speed. This extremely 
rapid mechanotransduction has brought forth the notion that the mechanosensory 
transduction in neuronal systems must be mediated by ion channels or ion channel 
complexes (Chalfie, 2009; Ernstrom and Chalfie, 2002).  
1.1.3 Ion channels in mechanotransduction 
The first discovery of ion channels that can be activated by mechanical forces was made 
in embryonic chick skeletal muscle and frog muscle (Brehm et al., 1984; Guharay and 
Sachs, 1984).  For an ion channel to be classified as a bona fide mechanically activated 
(MA) channel it must fulfil certain criteria; firstly, it must be expressed in the 
mechanosensory organ to facilitate its sensory function. Secondly, the channel must be 
inherently mechanosensitive and contain the pore-forming subunit within itself. Thirdly, 
loss of the channel in the sensory cell should abolish the mechanosensitive property of 
the cell. This condition is necessary (but not sufficient) to prove that an ion channel is the 
bona fide mechanotransducer. And fourthly, the channel should retain its 
mechanosensitivity when expressed in heterologous systems or lipid bilayers (Arnadóttir 
and Chalfie, 2010; Ranade et al., 2015). The bacterial mechanosensitive channels 
provide a good example of fulfilling these criteria. Mechanically gated channels in 
bacteria respond to hypo-osmotic shock/stress conditions by allowing the release of 
solutes. Two of these channels have been shown to be bona fide mechano-gated 
channels; Mechanosensitive channel of large conductance (MscL) and Mechanosensitive 
channel of small conductance (MscS). Loss of these channels (only both together) 
causes loss of response to osmotic shock in bacteria. Point mutations in the genes 
encoding these channels can alter the osmotic responses of the bacteria, and lastly and 
most importantly, these channels when reconstituted in liposomes can be activated by 
pressure without the need for additional components. Taken together, this illustrates that 
MscL and MscS are the bona fide mechanically gated channels in bacteria (Arnadóttir 
and Chalfie, 2010). Besides the above mentioned bacterial channels, few candidates 
have been discovered that meet all the criteria described above. In the next section, I 
discuss mechanotransduction in the context of sensory systems and more specifically the 
somatosensory system. 
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1.1.4 Sensory mechanotransduction  
As mentioned earlier, mechanotransduction is a requirement for many physiological 
functions such as the pulmonary, vascular and cardiovascular systems (Ranade et al., 
2015). But in this study, I focus on the role of mechanotransduction in the sensory 
systems. The study of mechanically gated channels in sensory systems has been 
confounded with technical difficulties which make progress slow. Firstly, the sparsity of 
the ion channel receptors in sensory cells or peripheral receptors makes biochemical 
characterization fairly difficult. Secondly, the absolute numbers of these channels are low, 
for example only 50-100 copies of the transduction channel are thought to be expressed 
in each vertebrate hair cell. And lastly, a key criteria for bona fide channels; functional 
expression in heterologous systems has proved to be a challenge (Chalfie, 2009).  
Despite these difficulties, to date four classes of ion channels have been identified that 
satisfy the above mentioned requirements for bona fide mechanosensitive channels in 
eukaryotes; DEG/ENaC, TRPN, TMCs and Piezos (Delmas and Coste, 2013). 
The DEG/ENaC (degenerin/Epithelial Sodium Channel, Ranade et al. (2015)) channels 
are expressed in the touch receptor neurons of C. elegans where they can be mutated to 
produce touch insensitive mutants (Chalfie, 2009). The mechanosensitivity in these 
neurons is conferred by a protein complex consisting of MEC-4 and MEC-10 (DEG/ENaC 
proteins that are the pore forming subunits of the complex) and MEC-2 and MEC-6 which 
regulate the complex (Arnadóttir and Chalfie, 2010). Among the TRP (transient receptor 
potential), channels various members have shown potential mechanosensitivity. One 
particular member NompC (TRPN) was shown to be the mechanotransduction channel 
for gentle touch in Drosophila (Yan et al., 2013). A loss of NompC (no mechano-receptor 
potential), as the name suggests, leads to loss of mechanically induced receptor potential 
in the bristle mechanosensors of the fly (Chalfie, 2009). Additionally, two Drosophila 
TRPV genes, Nanchung and Inactive, and TRPA1 ortholog, Painless are necessary for 
touch and hearing in flies, while the TRPA1 ortholog in C.elegans is involved in 
somatosensation (Ranade et al., 2015).  In mammals, TRPA1 was shown to be 
expressed in small diameter DRG neurons and mediate slowly adapting mechanically 
activated (SA-MA) currents in C-fiber type (small diameter) sensory neurons (Vilceanu 
and Stucky, 2010). The next class of bona fide MA channels was described in the context 
of mammalian hearing. For a long time the auditory mechanotransducing channel 
remained elusive and various known ion channel families including TRP channels were 
implicated (Ranade et al., 2015). In 2011, the TMC1 and TMC2 (Transmembrane 
channel 1 and 2) were shown to be required for hair cell mechanotransduction (Delmas 
and Coste, 2013). Besides these channels, two more components, TMHS (tetra-span 
membrane protein of hair cell stereocilia) and TMIE (transmembrane inner ear expressed 
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gene) were shown to be necessary components of the transducing apparatus (Ranade et 
al., 2015).  
The breakthrough in mammalian somatosensation happened in 2010. Using an extensive 
siRNA screening Coste and colleagues, identified Piezo1 and Piezo2 as being bona fide 
mechanosensitive ion channels (Coste et al., 2010; Coste et al., 2012).  
1.2 Piezo protein family 
Piezo proteins are multi-pass transmembrane proteins with very little similarity to any 
known protein family. A single Piezo protein has been found in many animal, plant and 
eukaryotic species. Vertebrates express two members of the Piezo family i.e. Piezo1 
(Fam38A) and Piezo2 (Fam38B). Piezo1 is strongly expressed in bladder, colon, kidney, 
lung, bone, red blood cells and skin (Coste et al., 2010; Wu et al., 2016b). It shows 
relatively low mRNA expression in DRG (dorsal root ganglia; which contain cell bodies of 
somatosensory neurons). Piezo2 on the other hand shows strong expression in the DRG 
sensory neurons, which points to its role in somatosensory mechanotransduction. 
Besides DRG neurons, Piezo2 is also expressed in Merkel cells in the skin, chondrocytes 
in the bone, bladder, colon and lung (Coste et al., 2010; Wu et al., 2016b). Piezo protein 
function assayed in DRG neurons, N2A cells and HEK293 cells showed that both Piezo1 
and Piezo2 generate MA currents. These currents are characterized by a rapid activation 
and inactivation. In a subsequent study, it was shown that Piezos are indeed pore-
forming ion channels that mediate MA currents. Piezos are non-selective cation channels 
with a mild Ca2+ preference. In near physiological conditions single-channel conductance 
of mouse Piezo1 (mPiezo1) is approximately 29pS and approximately 24pS for mouse 
Piezo2 (mPiezo2) (Coste et al., 2012; Wu et al., 2016b). Several pharmacological agents 
have been shown to modulate Piezo channels. Ruthenium Red and Gadolinium, known 
blockers of many cationic MA currents also block Piezo1 and 2 in a reversible manner, in 
C2C12 cells (Coste et al., 2010). Another molecule, FM1-43, a styryl dye was shown to 
permeate mechanosensitive ion channels in DRG neurons and block all MA currents 
from these cells including Piezo2-mediated currents (Drew and Wood, 2007; Eijkelkamp 
et al., 2013). Additionally, GsMTx4 (peptide toxin from Grammostola spatulata spider 
venom) non-specifically blocks cation-selective stretch sensitive channels including 
Piezo1 and Piezo2 (Alcaino et al., 2017; Bagriantsev et al., 2014). Besides these non-
specific inhibitors of Piezo channels, recently, Yoda1 was described as a chemical 
activator of Piezo1 (Piezo2 is resistant to Yoda1). Yoda1 was capable of sensitizing 
mPiezo1 activation and slowing the inactivation phase of the MA current. In cell-attached 
patch configuration of Piezo1 over expressing HEK293 cells, Yoda1 application was also 
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capable of generating small currents in the absence of mechanical stimulus (Syeda et al., 
2015).    
1.2.1 Structure of Piezo proteins  
A distinct feature of Piezo channels is their large size; mPiezo1 contains 2547 amino 
acids while mPiezo2 contains 2822 amino acids (Soattin et al., 2016). These proteins are 
not similar to any known proteins or ion channels. Within the Piezo family, mPiezo1 and 
mPiezo2 show 39% sequence similarity (based on NCBI BlastP tool; Soattin et al. (2016). 
Although the details of Piezo structure remain to be unambiguously characterized, they 
have been proposed to contain over 18 transmembrane domains making them one of the 
largest ion channel complexes identified so far (Figure 2A; Ranade et al. (2015)).  The 
first study to identify structural motifs in Piezo channels was conducted by Kamajaya and 
colleagues in 2014. They found that the C-terminal loop 2 (CTL2) domain forms a 
previously uncharacterized β-sandwich fold structure. This domain was identified in the 
C.elegans Piezo structure, and found to be relatively conserved across homologs. The 
authors postulated a role for this domain either in trafficking, tethering or ligand binding 
(Kamajaya et al., 2014). Subsequent studies on Piezo1 structure, found the C-terminal 
region (residues 1974 to C-term) essential for its ion permeation properties. Further, it 
was also identified that a conserved amino acid residue (E2133 in mPiezo1) which is in 
the vicinity of the ion permeation domain can alter the pore-dependent properties of the 
channel (Coste et al., 2015). In 2016, two groups identified more details of the Piezo1 
structure using cryo-electron microscopy (cryo-EM) and structure-guided functional 
studies (Xu, 2016). These studies revealed that Piezo1 consists of peripheral 
transmembrane domains which assemble as a propeller with three curved ‘blades’. This 
makes up the mechanosensing domain of the channel. In addition the two 
transmembrane segments in the C-terminal region encase the channel pore topped by a 
cap-like C-terminal extracellular domain (CED) (Figure 2B and 2C; Ge et al. (2015), Wu 
et al. (2016b) and Zhao et al. (2016)). The latest study exploring Piezo1 structure used 
magnetic nanoparticles to apply localized mechanical forces combined with pressure-
clamp electrophysiology to identify two mechanosensitive domains in the Piezo1 
structure (Wu et al., 2016a). In the case of Piezo2 channels, structural studies have not 
been conducted so far and it remains to be seen if similar gating mechanisms operate in 
Piezo2. Though, the similarities in the two proteins in their size and predicted topology as 
well as the 54% sequence similarity in the C-terminal pore domain (transmembrane 
segments and C-terminal extracellular domain) could be indicative of similar architecture 
(Wu et al., 2016b).  
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1.2.2 Piezo2 in somatosensory mechanotransduction 
As mentioned earlier the Piezo proteins are expressed in variety of tissues and cell types. 
Piezo1 shows a largely non-sensory distribution while Piezo2 is highly enriched in the 
DRGs. The DRG neurons can be anatomically categorized into large, medium and small 
diameter neurons wherein the large diameter neurons are thought to be 
mechanoreceptor neurons while the medium and small diameter neurons are considered 
nociceptor neurons (Julius and Basbaum, 2001). These different populations express 
marker proteins such as Peripherin, Neurofilament 200 (NF200) etc. Piezo2 is expressed 
in a subset of DRG neurons expressing NF200 and Peripherin (markers of 
mechanosensory neurons). A small percentage of overlap was also observed with 
TRPV1 (marker of nociceptive neurons) (Coste et al., 2010). Further, DRG neurons can 
be classified functionally based on the type of MA current they exhibit.  One can identify 
three types of MA currents based on their inactivation time constant (τ). τ < 10ms are 
referred to as Rapidly adapting (RA) currents; 10ms < τ < 30ms are the Intermediately 
Figure 2: Structure of Piezo proteins  
(A) Predicted topological structure of mPiezo2 as obtained using the transmembrane hidden Markov model 
(TMHMM). The structure of mPiezo2 remains to be resolved and this model only serves as a prediction for 
the possible structure of the channel. (B) Illustration of the topological model and (C) structural model for 
mPiezo1 as determined by cryo-electron microscopy shows two distinct domains, namely the peripheral 
domain (peripheral helices; PH) which assembles into the mechanotransducing propeller ‘blade’ structure 
and the C-terminus pore region capped by the C-terminal extracellular domain (CED). CTD: C-terminal 
domain; OH: Outer helix; IH: Inner helix. Adapted from Delmas and Coste (2013) and Zhao et al. (2016) 
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adapting (IA) currents; and τ > 30ms are the Slowly adapting (SA) currents (Coste et al., 
2010). It was shown that upon siRNA mediated knockdown of mPiezo2 from primary 
cultures of DRG neurons, the proportion of neurons showing RA-MA currents was 
significantly reduced and the neurons not responding to mechanical stimulus were 
concomitantly increased. The fact that the other MA current populations remain 
unaffected showed that Piezo2 specifically mediates RA-MA currents in these neurons 
(Coste et al., 2010). At the periphery, somatosensory neurons can be divided into two 
broad categories; High-threshold mechanoreceptors (HTMRs) and low-threshold 
mechanoreceptors (LTMRs). The HTMRs respond to noxious range of mechanical 
somatosensory stimuli while the LTMRs respond to innocuous/benign stimuli. The nerve 
fibers associated with these receptors are Aβ fibers, Aδ and C-fibers. The Aβ fibers have 
low mechanical thresholds and are therefore suited to be detectors of light touch. The 
majority of Aδ and C-fibers are believed to be nociceptors/detectors of noxious stimuli. 
Though, there are subsets of the Aδ and C-fibers that have also been implicated in light 
touch due to their considerably lower thresholds. These fibers innervate hairy and 
globular skin and the combination of these fibers allows us to experience the different 
modalities of the sense of touch (Abraira and Ginty, 2013; Roudaut et al., 2012). In hairy 
skin, these fibers innervate hair follicles, where they form longitudinal and circumferential 
lanceolate endings (Abraira and Ginty, 2013). Some C-fibers also form free nerve 
endings which contain both noxious mechanoreceptors and low threshold 
mechanoreceptors (Roudaut et al., 2012). In conjunction with its identification in large 
diameter DRG neurons, Piezo2 was also identified in nerve endings in the hairy skin of 
mice. Piezo2 was identified in longitudinal and circumferential lanceolate endings 
innervating hair follicles (Ranade et al., 2014). Glabrous skin contains slow and rapidly 
adapting receptors. Merkel cells (modified epidermal cells) form a complex with the 
slowly adapting LTMRs while Meissner and Pacinian corpuscles form part of rapidly 
adapting complexes (Abraira and Ginty, 2013). Sensory fibers form specialized 
complexes with modified epidermal cells for example the Merkel cell-neurite complex. In 
a series of studies published recently it was established that Merkel cells are inherently 
mechanosensitive and express Piezo2. The sensory afferent (also expressing Piezo2) 
forms a complex with Merkel cells which could be the basis for highly sophisticated 
responses to mechanical stimuli (Ikeda et al., 2014; Maksimovic et al., 2014; Woo et al., 
2014). In order to understand more about the functions of Piezo2, Ranade and 
colleagues, generated an inducible Piezo2 knockout mouse (constitutive Piezo2 deletion 
is lethal in mice Dubin et al. (2012) and Ranade et al. (2014)). The inducible deletion of 
Piezo2 was done in sensory neurons and epidermal Merkel cells using the Advillin 
promotor. These animals show a pronounced loss of touch sensation, without any 
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significant differences in the nociceptive functions (Ranade et al., 2014).  Further, Piezo2 
was also shown to be the principle mechanotransduction channel for proprioception (both 
body and head) again using mouse lines that specifically deleted Piezo2 in proprioceptive 
neurons. These mice showed uncoordinated body movements and abnormal limb 
positions, both signs of proprioceptive defects (Florez-Paz et al., 2016; Woo et al., 2015). 
Interestingly, Piezo2 was found to be required for mechanotransduction in human stem 
cell-derived touch receptors (Schrenk-Siemens et al., 2014) and in a subsequent study 
two patients with loss-of-function mutations in Piezo2 were identified. These patients 
showed pronounced deficits in touch, vibration and proprioception, while mechanical and 
thermal pain threshold were comparable to controls (Chesler et al., 2016). This provides 
additional evidence that mammalian Piezo2 is essential for tactile sensory information, 
but may not play an essential role in nociception.  
Despite the above mentioned studies, new evidence is accumulating for the role of 
Piezo2 in nociception. Firstly Piezo2 expression was found in small diameter DRG 
neurons where it overlaps with TRPV1, a known mediator of nociception (Coste et al., 
2010). Additionally, proalgesic peptide, bradykinin could potentiate Piezo2 mediated MA 
currents. In case of nociceptors, such heightened function contributes to increased 
sensitivity to pain (hyperalgesia). The role of TRPV1 in thermal hyperalgesia is well 
defined, but the potentiation of Piezo2 by inflammatory mediators, suggests that its 
sensitization may play a role in mechanical hyperalgesia (Dubin et al., 2012). Another line 
of evidence came from Eijkelamp and colleagues, who showed that Epac1 (cyclic AMP 
sensor) causes potentiation of RA-MA (Piezo2 mediated currents) and contributes to 
mechanical allodynia (when innocuous stimuli are perceived as painful). Epac1 is a 
guanine nucleotide exchange factor, which is required for the development of allodynia in 
the mouse model of neuropathic pain (Eijkelkamp et al., 2013). Further, Piezo2 was 
shown to play a role in stimulus-dependent mechanical hyperalgesia in endothelial cells 
(Ferrari et al., 2015). This shows that though Piezo2 may not be the main channel 
involved in nociception, its regulation may play a role in nocifensive behaviors like 
mechanical allodynia and hyperalgesia (Lolignier et al., 2014). 
1.2.3 Pathology associated with Piezo2 
As mentioned in the last section, complete ablation of Piezo2 in mice is perinataly lethal 
(Dubin et al., 2012; Ranade et al., 2014), presumably due to defects in lung development. 
But several mutations have been described in human Piezo2, some of which produce 
inactive channels. Interestingly, humans only show sensory-motor phenotypes upon lack 
of functional Piezo2 (in clear contrast to mice) (Chesler et al., 2016). Distal arthrogryposis 
type 5 (DA5), Gordon Syndrome and Marden-Walker syndrome are some of the 
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conditions directly linked to Piezo2. The patients present with joint and muscle 
contractures, cleft palate and developmental delay among other symptoms (Coste et al., 
2013; McMillin et al., 2014). The differences between the mouse and human Piezo2 and 
its deletion still remain to be understood. 
1.3 Protein complexes associated with ion channels 
1.3.1 Ion channel function and protein complexes  
Ion channels are integral membrane proteins usually containing a pore domain spanning 
the lipid bilayer and allowing the diffusion of ions. These channels are gated by multiple 
mechanisms such as ligands, voltage or mechanical stimuli. An important requirement for 
these channels is to modulate channel opening and closing in response to extra or 
intracellular signals. It is widely known that ion channels often exist as part of dynamic 
multi-protein complexes. These interacting proteins could either be subunits required for 
the channel assembly and function, or they could be additional proteins that associate 
with the ion channels and regulate its properties. Other parts of this complex could be 
proteins relevant for the targeting of ion channels, membrane modifying proteins, 
cytoskeletal elements, all of which are essential for channel function and regulation 
(Levitan, 2006).  
1.3.2 Protein complexes in mechanotransduction 
As with other ion channels, mechanosensitive ion channels also appear to exist as part of 
protein complexes. Though the knowledge of these complexes in mammals is 
incomplete, evidence from C. elegans and Drosophila is very strong. In C. elegans the 
mechanotransducing channel complex MEC-10, MEC-6 and MEC-4 are supported by 
extracellular (MEC-5) and intracellular (MEC-7, MEC-12) anchor proteins. Extracellular 
linker MEC-9 links the channel to the extracellular anchor and stomatin-like protein MEC-
2 links the channel to cytoplasmic microtubules (Figure 3A). In Drosophila, a very similar 
arrangement is seen where the transduction channel (NompC) is linked to an 
extracellular anchor and cytoplasmic microtubules through linker proteins (Figure 3B). 
And in the mammalian auditory system, despite the debate around the transduction 
channel (Ranade et al., 2015), several regulators of the complex have been identified 
(Figure 3C; Gillespie and Walker (2001)). The question if similar complexes exist in 
mammalian somatosensory mechanotransduction remains open.  
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1.3.3 Protein complexes in mammalian somatosensation 
Though the protein complexes associated with mammalian somatosensation have not 
been completely discerned, there is evidence for some proteins that modulate 
mechanotransduction in this system. The first such evidence was the identification of 
Stoml3 (Stomatin-like protein 3, SLP3) as a crucial protein for somatic touch. Stoml3 is a 
homolog of the C. elegans MEC-2 protein which is required for touch receptor function. 
Stoml3 is required for the expression of mechanosensitive currents in a subset of DRG 
neurons as well as for mechanical sensitivity in vivo (Hu et al., 2010; Wetzel et al., 2007). 
Figure 3: Illustrations of mechanosensitive channel complexes 
(A) Proposed model of mechanotransduction complex in C. elegans indicating the hypothetical locations of 
MEC proteins that form integral components of the mechanosensing apparatus in the mechanoreceptors. 
(B) Proposed molecular model of mechanotransducing machinery in the ciliated Drosophila 
mechanoreceptor and (C) proposed molecular model of the mammalian auditory inner hair cell 
mechanotransduction apparatus. Adapted from Gillespie and Walker (2001) 
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In subsequent studies, after the discovery of the Piezo2 protein it was shown that Stoml3 
modulates Piezo2 activity by influencing local membrane properties (Poole et al., 2014; 
Qi et al., 2015). Another interesting modulator of somatic touch is Runx1, a transcription 
factor which was shown to be essential for the expression of VGLUT2 and TH (tyrosine 
hydroxylase) in LTMRs. It was also required for the formation of longitudinal lanceolate 
endings, which are LTMRs innervating the hair follicles in the skin. Interestingly, the role 
of Runx1 in establishing mechanosensitivity in LTMRs is through regulation of Piezo2 
expression (Lou et al., 2013). Additionally, potassium channel subunits (Kcna1/Kv1.1 and 
Kcna2/Kv1.2) were shown to regulate adaptation of distinct mechanoreceptor populations 
(Hao et al., 2013). The most recently identified regulator of somatic touch is CaMKII 
(Ca2+/calmodulin-dependent kinase II). It was shown to mediate activity dependent 
plasticity in somatic touch and adequate levels of CaMKII function was essential to 
prevent allodynia like conditions (Yu et al., 2015).  
1.3.4 Piezo2 associated proteins (Piezo2 interactors)  
As mentioned above very few modulators of somatic touch and interactors of Piezo2 
have been identified so far (Figure 4). The first study that systematically identified the 
interactors of native Piezo2 was reported by our group in 2016. The study used 
immunoprecipitation followed by highly sensitive liquid chromatography (LC)-coupled 
tandem mass-spectrometry (MS/MS) to identify interactors of native Piezo2 from DRG 
tissue of mice (summarized in Figure 5; Narayanan et al. (2016)). For this screen firstly, 
commercial Piezo2 antibodies were tested for specificity in immunoprecipitating native 
Piezo2 from sensory neurons. Figure 6A depicts the specificity of Piezo2 Ab1 (Piezo2) in 
detecting Piezo2 compared to Piezo2 Ab-2 and IgG controls. Then, using the positive 
Piezo2 antibody, native Piezo2 was immunoprecipitated from DRGs and the resulting 
mixture was subjected to mass-spectrometry. Through this screen 36 proteins were 
identified as potential interactors of Piezo2 in somatosensory neurons (Figure 6B). 
Candidates identified in the screen were analyzed using Gene ontology analysis using 
the DAVID bioinformatics resource and STRING visualization tool (Figure 6C and 6D; 
Huang da et al. (2009) and Huang et al. (2009)). The identified proteins belonged to 
various categories, including cellular trafficking, cytoskeletal proteins and ion channels. 
Identification of known modulators of somatosensory mechanotransduction like Kcna1 
and 2 and CamKII (as discussed in the previous section) suggests that this screen 
successfully identified proteins relevant to somatosensory mechanotransduction. In the 
current study, two candidates identified from this screen were characterized as functional 
interactors of mPiezo2.  
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Figure 5: Scheme of mass-spectrometry (MS) based interactomics approach to identify Piezo2 
interactors 
Interactors of native Piezo2 were identified from sensory neurons of mouse using immunoprecipitation 
followed by mass-spectrometry. DRG tissue was isolated from  WT C57BL/6J mice and subjected to 
immunoprecipitation using a positively tested anti-Piezo2 ab. The immunoprecipitate was subjected to LC-
MS/MS (Liquid chromatography coupled mass-spectrometry). Label free quantification with stringent 
statistical criteria based on significance scores  was used to discriminate hits from the background. 
Reprinted (adapted) with permission from Narayanan et al. (2016). Copyright (2016) American Chemical 
Society.  
Figure 4: Identified components of mammalian somatosensory complex.  
CaMKII and Kv1.1 modulate adaptation and plasticity in the somatosensory system. STOML3 is shown to 
directly interact with Piezo2 and is essential for somatic touch. Runx1 is a transcription factor required for 
proper formation of specialized peripheral endings, through regulation of Piezo2 expression.   
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Figure 6: Quantitative mass-spectrometry (MS) based interactomics approach to identify Piezo2 interactors 
(A) Quantitative mass-spectrometry using specific Piezo2 antibody (Piezo2) successfully detects Piezo2 
peptides in sample but not in controls (IgG and negative Piezo2 antibody (Piezo2-Ab2)) (B) Volcano plot of 
mean fold change versus negative log10 p-value, showing the members of the Piezo2 interactome. The top 
right quadrant illustrates candidates which passed the statistical criteria to be described as true interactors. 
(C) Assigned Gene ontology (GO) biological process categories and the relative abundance of each 
category in the above identified Piezo2 interactome. (D) STRING visualization of physical and functional 
associations which were identified between candidates of the Piezo2 interactome. Reprinted (adapted) with 
permission from Narayanan et al. (2016). Copyright (2016) American Chemical Society. 
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1.4 Potential Piezo2 interactors: Pericentrin (Pcnt) and Mtmr2 
1.4.1 Pericentrin  
Pcnt was first identified in mice as a 220 kDa protein, found in centrosomes and non-
centriolar microtubule organizing centers (MTOC) (Doxsey et al., 1994). It was later 
identified that Pcnt exists as three splice variants, namely Pcnt A (220-250 kDa), Pcnt B 
(>350 kDa) and Pcnt S (220 kDa) (Figure 7; Miyoshi et al. (2006) and Mühlhans and 
Gießl (2012)). Pcnt is a large coiled-coiled protein, which is expressed in the 
pericentriolar material (PCM) surrounding the centrosome and in basal bodies of primary 
cilia (Delaval and Doxsey, 2010). It serves as a multifunctional scaffold and plays a role 
in cell cycle regulation, mitotic spindle assembly and orientation, and primary cilia 
assembly and development (Delaval and Doxsey, 2010). Due to the key cellular 
processes Pcnt is involved in, it is also linked to various disorders. Some of these 
disorders include, microencephalic osteodysplastic primodial dwarfism (MOPDII), chronic 
myeloid leukemia (CML) and mental disorders like schizophrenia (Delaval and Doxsey, 
2010). Various binding partners of Pcnt have been identified to date. The motor protein 
dynein is involved in the transport of Pcnt to the centrosome and the assembly of the 
mitotic spindle. The process is mediated by Pcnt binding of dynein light intermediate 
chain (Purohit et al., 1999). Another interesting interactor of Pcnt is the pericentriolar 
material 1 protein (PCM-1), which is required for the localization of Pcnt to the 
centrosomes (Dammermann, 2002; Li et al., 2001). It is relevant to note here that PCM-1 
was also identified in the native Piezo2 interactome described earlier (Narayanan et al., 
2016). Additionally, Pcnt has also been implicated in the regulation of secretory vesicle 
docking and insulin secretion in pancreatic β-cells through its interaction with F-actin 
(Jurczyk et al., 2010; Zu et al., 2015). Further, in its function as a potential scaffold at the 
base of primary and motile cilia, Pcnt interacts with cation channel polycystin-2 (PC2) 
(Jurczyk et al., 2004). Interestingly, PC-1 and 2 have been suggested to function in 
mechanotransduction in the primary cilium of renal epithelia (Nauli et al., 2003).  
 
 
 
 
 
Figure 7: Pericentrin structure and isoforms 
Illustration of Pericentrin isoforms, Pericentrin A, B and S. In mice, Pcnt B is the largest isoform with a 
molecular weight of 360 kDa. Two smaller isoforms Pcnt S (250 kDa) and Pcnt A (220-250kDa) have also 
been described in mice. Adapted from Mühlhans and Gießl (2012). 
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1.4.1.1 Pericentrin in sensory systems 
Pcnt has also been shown to play a role in sensory systems. In mouse photoreceptors, 
Pcnt is expressed in the connecting cilium, which bridges the outer and inner segments 
of the photoreceptor. Pcnt localizes to the basal body complex where it is involved in 
transport of proteins between the two segments (Mühlhans et al., 2011). Pcnt is also 
expressed in the olfactory cilia of chemosensory neurons in the nasal olfactory 
epithelium. Mutations in Pcnt cause malformation of the cilia and reduce olfactory 
performance (Miyoshi et al., 2009). Furthermore, Pcnt mutant mouse displays an 
impaired interneuron migration to the olfactory bulb (Endoh-Yamagami et al., 2010). 
Another interesting role for Pcnt was described in Drosophila. The Drosophila Pcnt-like 
protein (D-PLP), is essential for cilia and flagella function in flies, while it appears to be 
dispensable for mitosis. D-PLP mutant flies show defects in mechanosensory cilia and 
are phenotypically, uncoordinated (Martinez-Campos et al., 2004).  
Through this study I ask if Pcnt interacts with mPiezo2 and plays a role in mammalian 
somatosensory mechanotransduction.  
1.4.2 Myotubularin related protein-2 (Mtmr2) 
Myotubularin-related proteins (MTMRs) are a family of conserved protein tyrosine/dual 
specificity phosphatase-like phosphatases (Laporte et al., 1998). There are 14 members 
in the family, of which eight are catalytically active while six are catalytically inactive 
members (Lorenzo et al., 2006). MTMR proteins share certain structural features, namely 
an N-terminal GRAM domain, a PTP-like catalytic domain, a coiled-coil domain and C-
terminal domains such as PDZ or FYVE (Begley et al., 2006; Lorenzo et al., 2006). 
Mtmr2 is a 643 amino acid long, catalytically active member of this family (Figure 8A; 
Bolino et al. (2002)). Mtmr2 has been studied largely with regard to its role in the 
peripheral neuropathy Charcot-Marie-Tooth disease Type 4B1 (CMT4B1) (Bolino et al., 
2004; Bolis et al., 2005; Previtali et al., 2007). Though MTMRs are structurally similar to 
the protein tyrosine phosphatases, they do not use phosphoproteins as substrate. The 
MTMR family, specifically dephosphorylates the D3 position of phosphoinositide 
phosphates like phosphatidylinositol 3-phosphate (PI(3)P) and phosphatidylinositol (3,5)-
bisphosphate (PI(3,5)P2) (Begley et al., 2006). Mtmr2 is also capable of 
dephosphorylating both PI(3)P and PI(3,5)P2, but shows higher efficiency towards 
PI(3,5)P2 (Figure 8B; Berger et al. (2002)). As expected from its role in peripheral 
neuropathy, Mtmr2 shows strong expression in the peripheral nervous system (studies in 
mice and rats). Dorsal root ganglia and spinal roots show abundant Mtmr2 mRNA 
expression starting from early developmental stages (Bolino et al., 2002). Mtmr2 has 
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been detected in the cytoplasm of both myelin forming and non-myelin forming Schwann 
cells in the sciatic nerve of mice and rats. It also shows strong expression in both sensory 
and motor neurons that send axons to the peripheral nerves. The cell bodies and axons 
of these neurons showed Mtmr2 staining (Previtali et al., 2003). In terms of sub-cellular 
localization, Mtmr2 is known to express in the cytosol or associate with the peripheral 
membranes. In some cases it has been shown to have a nuclear localization though the 
role of this remains unclear (Previtali et al., 2007; Previtali et al., 2003). Of note, Mtmr2 
when overexpressed in mammalian cells, localizes to the cytosolic compartment (Ng et 
al., 2013).   
 
 
 
 
 
 
 
 
 
 
 
1.4.2.1 Mtmr2 interactors 
Because of the important role Mtmr2 plays in CMT4B1, it has been the subject of various 
studies to understand its cellular function and how it could contribute to disease 
progression. The presence of active and inactive phosphatases in the MTMR family has 
led to speculation that they may interact to regulate each other. Two such interactions 
have been characterized for Mtmr2, namely with Mtmr5 (Sbf1) and Mtmr13 (Sbf2) 
(Clague and Lorenzo, 2005; Lorenzo et al., 2006). Mtmr5 interacts with Mtmr2 through 
the coiled-coil domain and increases its enzymatic activity. Mtmr5 (catalytically inactive 
phosphatase) is also responsible for dictating the subcellular localization of Mtmr2 (Kim 
et al., 2003). Interestingly, Mtmr5 (Sbf1) was also identified as a potential member of the 
Piezo2 interactome in sensory neurons (Narayanan et al., 2016). The other interaction 
Figure 8: Mtmr2 structure and phospholipid catalysis pathway  
(A)  Mtmr2 is the catalytically active member of the MTMR phosphatase family. Illustration of Mtmr2 
structure depicting the different structural motifs; PH-GRAM domain, phosphatase domain and PDZ binding 
domain. Adapted from Begley et al. (2006). (B) Illustration of the phosphatidylinositide pathway, which 
involves Mtmr2 as a 3-phosphatase.   
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between MTMR family members is between Mtmr2 and Mtmr13 (Sbf2). In this case, 
Mtmr2 is responsible for localizing and stabilizing Mtmr13 (catalytically inactive 
phosphatase) at endomembranes and both proteins are dependent on each other to 
maintain their levels in the cell (Ng et al., 2013). Besides its interactions with members of 
the MTMR family of proteins, Mtmr2 also interacts with other proteins both in neurons 
and Schwann cells. Using a yeast two-hybrid screen, neurofilament light chain protein 
(NF-L) was shown to interact with Mtmr2 in neurons and Schwann cells. It was postulated 
that NF-L may be involved in targeting Mtmr2 to its site of action, and aide the role of 
Mtmr2 in plasma membrane remodeling (Previtali et al., 2003). Another interaction 
characterized in Schwann cells, was with Discs large 1(Dgl1). This interaction is 
responsible for negative regulation of membrane addition and its disruption may be 
responsible for the characteristic myelin out folding phenotype of CMT4B1 (Bolis et al., 
2009). Additionally, Mtmr2 was also shown to localize to synapses of excitatory neurons 
through interactions with PSD-95. Loss of Mtmr2 from these neurons causes lowered 
synaptic density and function. Interestingly, this interaction requires a catalytically active 
phosphatase, indicating a role for PI(3)P or PI(3,5)P2 in the interaction (Lee et al., 2010). 
In a subsequent study, Mtmr2 was shown to interact with Fig4. Fig4 plays a role in 
synthesis of PI(3,5)P2 while Mtmr2 dephosphorylates it. The study showed that Fig4 
downregulation was able to counteract the effects of Mtmr2 deletion in mice (Vaccari et 
al., 2011).  In summary, Mtmr2 plays an important role in sensory neurons and Schwann 
cells and its cellular targets PI(3)P and PI(3,5)P2 are relevant for these roles.  
1.4.2.2 Phosphatidylinositol lipids 
Phosphorylated phosphatidylinositol (PIP) lipids regulate a variety of cellular processes. 
Seven members of this family have been identified in mammals of which the cellular role 
of PI(4,5)P2 is most studied (Jin et al., 2016). The precursor to these PIPs is the 
abundant membrane lipid phosphatidylinositol (PI). Tightly regulated kinases and 
phosphatases control the synthesis and turnover of these PIPs (McCartney et al., 2014a). 
As mentioned above, Mtmr2 is involved in the dephosphorylation of two members of this 
family i.e. PI(3)P and PI(3,5)P2. PI(3,5)P2, is a member of the above family but has a 
relatively low abundance in the cell compared to other PIPs. In mammalian cells, it 
accounts for approximately 0.05%-0.1% of the total phosphatidylinositol lipids which is 
about 125-fold less abundant than PI(4,5)P2 (Jin et al., 2016; McCartney et al., 2014a). 
PI(3,5)P2 levels show dynamic and transient changes upon exposure to cellular stress 
such as osmotic shock in both yeast and mammalian cells. This suggests a role for 
PI(3,5)P2 in cellular homeostasis and adaptation (Jin et al., 2016; McCartney et al., 
2014a). The dynamic changes in the levels of this PIP also indicate a tightly regulated 
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synthesis and turnover. In mammalian cells, only one pathway is known to synthesize 
PI(3,5)P2, which involves the Fab1/PIKfyve kinase. This kinase is further regulated by 
scaffolding proteins Vac14 and phosphatase Fig4 (Zolov et al., 2012). MTMRs, with their  
3-phosphatase activity are involved in the dephosphorylation of PI(3,5)P2 to generate 
PI(5)P. Mouse Mtmr2 has been shown to function with the Fab1/PIKfyve complex to 
generate PI(5)P (Vaccari et al., 2011).     
1.4.2.3 PI(3,5)P2 regulatory functions 
Despite its low abundance, PI(3,5)P2 plays an important regulatory role in cells. A study 
by Dong and colleagues, identified TRPML1 as a channel regulated by PI(3,5)P2 (Dong 
et al., 2010). Of note, TRP channels have been known to be regulated by the more 
abundant PI(4,5)P2 (Borbiro et al., 2015). The study showed that PI(3,5)P2 is able to 
activate TRPML1 in the endo-lysosomal membrane and further went on to show that 
PI(3,5)P2 binds directly to the N-terminal of TRPML1 (Dong et al., 2010). Another study 
showed that PI(3,5)P2 levels are dynamically regulated in active neurons. It implicated 
PI(3,5)P2 in the endocytosis and recycling of AMPAR (AMPA type glutamate receptor), 
which is in turn linked to activity dependent changes in synaptic strength (McCartney et 
al., 2014b). Besides these, various studies have looked at potential PI(3,5)P2 binding 
motifs and identified WD40 domain containing proteins for example Atg18, Atg21 etc. as 
potential PI(3,5)P2 binding proteins. PI(3,5)P2 also binds to and activates ryanodine 
receptors in the skeletal and cardiac muscles, to stimulate calcium release (McCartney et 
al., 2014a).  
Taken together, it can be seen that though low in abundance, PI(3,5)P2 can play crucial 
roles in regulation of cellular processes and it remains to be seen if it has a role in 
somatic touch.   
1.5 Aims of the study 
Tactile perception has remained a mystery in sensory neuroscience for a long time. While 
all other sensory systems are relatively well characterized from their molecules to 
processing pathways, tactile sensation and perception remained obscure.  
Only in 2010, the Piezo family was identified as bona fide mammalian mechanosensitive 
ion channels. Of these, Piezo2 has subsequently been implicated in light touch and 
proprioception making it the much needed stepping stone for understanding more about 
this fundamental sense. The complexity of tactile sensation requires the components of 
the system to be tuned to a wide range of stimuli. Anatomical features including high and 
low threshold receptors and slow and rapid adaptors are involved in the coding of 
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different aspects of touch. Besides these, the fundamental ion channel i.e. Piezo2 also 
needs to be regulated and modulated for further signaling. That, mechanically gated ion 
channels are tightly regulated by ion channel complexes is already known from 
C.elegans and Drosophila, but the evidence of such a complex is missing in mammals. 
Only few direct interactors of Piezo2 have been reported so far, namely STOML3 and 
Runx1. In 2016, through an interactomics based approach, 36 potential interactors of 
Piezo2 were identified.  
In the course of this thesis, I aimed to characterize two candidates identified in this 
screen, namely Pericentrin (Pcnt) and Myotubularin related protein-2 (Mtmr2) as potential 
Piezo2 interactors and modulators. 
The first candidate Pcnt, is best known for its role in cell cycle regulation and assembly of 
primary cilia. Through its role in the microtubule organizing complex, Pcnt has been 
involved in olfaction, vision and mechanosensation. In mammals however, this protein 
has not been characterized in the somatosensory systems. For this part of the study, my 
aim was to characterize Pcnt in the mouse peripheral somatosensory system and study 
its effect on Piezo2.  
The second part of this study involved the characterization of Mtmr2-Piezo2 interaction. 
Mtmr2 is a phosphatase known largely due to its role in the sensory motor neuropathy 
Charcot-Marie-Tooth disease type 4B1 (CMT4B1). Functionally, Mtmr2 is involved in the 
turnover of phosphatidylinositide phosphates (PIPs) particularly, PI(3)P and PI(3,5)P2. 
The aim of this part of the study was to characterize the interaction of Piezo2 and Mtmr2 
and identify if PI(3)P and PI(3,5)P2 lipids contribute to Piezo2 channel function or 
modulation.  
Overall, the questions asked in this study aim to uncover novel aspects of Piezo2 
regulation and modulation. 
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2. METHODS 
2.1. Verification of Piezo2-candidate interaction 
2.1.1. Transient transfection of HEK293 cells 
HEK293 cells were cultured in T-75 flasks at 37°C and 5% CO2, up to 80-90% 
confluency. Growth media consisting of DMEM with Glutamax supplemented with 10% 
Fetal Bovine Serum and 1% Penicillin/Streptomycin was used for the culture.  
For transfection, cells were plated onto 15cm cell culture dishes or 10mm poly-D-lysine 
coated coverslips. Cells were transfected with desired plasmids using FugeneHD 
transfection reagent. Transfection reagent master mix included Opti-MEM, DNA and 
FugeneHD (DNA:Fugene ratio 1:3). Transfection mix was pipetted evenly over the cells 
and they were allowed to grow for 48 hours at 37°C and 5% CO2. Transfection efficiency 
was checked by GFP fluorescence (from Piezo2-GST IRES GFP expression), observed 
using the Zeiss Axio Observer Z1 inverted microscope. Details of the plasmids used in 
the study are provided in supplementary table 1.  
2.1.2. Co-immunoprecipitation of Piezo2 and candidate from HEK293 cells 
HEK293 cells were transfected with Piezo2, co-transfected with mock or candidate (4µg 
each per dish), using FugeneHD transfection reagent. The cells were grown for 48 hours 
prior to harvesting. Cells were harvested in 1X PBS and lysed in buffer containing 5M 
NaCl, 1M Tris buffer, 1M Sucrose, 1M DTT, 1% DDM and protease inhibitor. The lysate 
was incubated overnight with glutathione coupled beads (Pierce Glutathione Magnetic 
beads) or Dynabeads Protein G coupled to the GST antibody. Elution was performed 
using buffer containing glutathione, reducing agent (NuPAGE sample reducing agent) 
and LDS (NuPAGE LDS sample buffer).  
Input and eluted fractions were loaded on a 3-8% Tris-acetate gel for gel electrophoresis. 
Protein was transferred onto nitrocellulose membrane using the iBlot Dry Blotting system 
(Life Technologies). The membrane was blocked with 5% non-fat milk for 30 minutes 
before probing with primary antibodies (diluted in 1% non-fat milk). Membrane was 
washed with 1X PBS and  probed with secondary antibody coupled to Alexa680 (diluted 
in 1% non-fat milk). Membrane was washed again and imaged using an Odyssey Infrared 
System (LI-COR). Details of antibodies used in this study are provided in supplementary 
table 2.    
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2.1.3. Immunohistochemistry 
Experimental methods 
C57BL/6J mice or Piezo2GFP (Woo et al., 2014) (between 8-9 weeks) were either 
euthanized with CO2 or perfused with 4% PFA. DRG and backskin were isolated from the 
animals and post fixed with 4% PFA and cryoprotected with 30% sucrose overnight. The 
tissue was then embedded in optimal cutting temperature medium and sectioned with a 
cryostat into 10µm thick sections, mounted onto SuperFrost Plus slides and stored at -
80°C.  For the staining, the slides were thawed at room temperature for 30 minutes. 
Tissue region on the slide was outlined using a hydrophobic pen and allowed to dry. The 
slides were then washed with 1X PBS and incubated with blocking solution (3% serum, 
0.4% TritonX-100 in 1X PBS) for 30 minutes at room temperature. Following this, the 
slides were incubated with primary antibody solution (primary antibody dissolved in 1% 
serum, 0.1% Triton-100 in 1X PBS), overnight at 4°C in a humidified chamber. After the 
overnight incubation, slides were washed thrice with 1X PBS. The slides were then 
incubated with the secondary antibody solution for 2 hours at room temperature in a 
humidified chamber. The slides were then washed again with 1X PBS and mounted with 
Slowfade Gold antifade reagent with DAPI and allowed to dry before imaging. In case of 
antibodies raised in mouse, the sections were incubated with donkey anti-mouse Fab 
fragments for 60 minutes at room temperature prior to staining with primary antibody. 
This prevented non-specific binding of anti-mouse secondary antibody to the tissue. For 
secondary controls, slides were stained with secondary antibody only. A list of all the 
antibodies used in this study is provided in Table 2. 
Image acquisition 
The slides were imaged using either the Zeiss Axio Observer Z1 inverted microscope or 
a Zeiss 510 meta confocal laser scanning microscope (CLSM). 10X, 20X air objectives or 
40X oil objectives were used. The imaging was always done keeping conditions constant 
for samples from the same experiments. Secondary controls were always imaged using 
the same conditions as sample sections.  
Analysis 
The analysis of immunostainings was done using NIH ImageJ (Schindelin et al., 2015). 
To identify the immuno-label positive cells, threshold was defined as: mean intensity (AU) 
+ 3*standard deviation of negative cells (10 random unstained neurons were chosen as 
negative cells) for each channel.  Positive cells were counted using the “cell counter” tool 
(NIH ImageJ). For analysis of immunolabel in nerve endings in the backskin sections, 
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optical sections were acquired with a Zeiss 510 meta confocal laser scanning microscope 
(CLSM) using the 40X oil objective. Noise removal and out of focus signal reassignment 
was conducted with the Huygens Essential deconvolution package (version 15.10, 
Scientific Volume Imaging) by applying a theoretical point spread function and the 
classical maximum likelihood estimation restoration method. Images were further 
processed with NIH ImageJ or Imaris 8.2.0 (Bitplane). Values are reported as mean ± 
SEM or percentages. Statistical analysis was done using unpaired t-test using GraphPad 
Prism 6.01(San Diego). 
2.1.4. Proximity ligation assay (PLA)  
Experimental methods 
PLA was carried out as described in Hanack et al. (2015) with minor modifications. DRG 
neurons or HEK293 cells were plated on MatTek dishes coated with poly-D-lysine 
(1mg/mL) and laminin (20µg/mL). HEK293 cells were transfected with Piezo2 and co-
transfected with mock or candidate construct (0.5µg each per dish). Cells were allowed to 
express the constructs for 48 hours before staining. Prior to staining, cells were washed 
with 1X PBS and fixed with 4% PFA for 10 minutes at room temperature. Thereafter cells 
were blocked in Duolink blocking solution for 2 hours at room temperature. Cells were 
then incubated with primary antibody (diluted in Duolink antibody diluent), overnight at 
4°C. [Preparation of antibody-conjugated PLA probe using the Duolink In Situ-
Probemaker kit: goat anti-chicken Alexa Fluor 647 (1mg/mL in 1X PBS) was mixed with 
Conjugation Buffer and added to lyophilize PLUS oligonucleotide. The mixture was 
incubated overnight at room temperature. Stop Reagent was added to the reaction and 
incubated at room temperature for 30 minutes. Conjugated antibody was stored in 
storage solution at 4°.] Cells were washed with wash buffer A (0.01M Tris, 0.15M NaCl 
and 0.05% Tween 20, pH 7.4) and incubated with PLA probes (Conjugated probes were 
diluted 1:200 in Duolink antibody diluent and commercial PLUS and MINUS probes were 
diluted 1:10 in Duolink antibody diluent) for 1 hour at 37°C. Cells were washed again with 
wash buffer A and incubated with amplification mix (amplification stock 1:5 and 
polymerase 1:80 in water) for 100 minutes at 37°C. Cells were then washed with wash 
buffer B (0.2M Tris, 0.1M NaCl, pH7.5) and kept in 1X PBS before imaging. Negative 
controls consisted of omission of either of the primary antibodies, while secondary 
controls were done by omitting all primary antibodies. A list of all the antibodies used in 
this study is provided in supplementary table 2. 
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Image acquisition 
The PLA was imaged using the Zeiss Axio Observer Z1 inverted microscope with a 40X 
oil objective. The imaging was always done keeping conditions constant for samples from 
the same experiments. Secondary controls were always imaged using the same 
conditions as sample sections. 
Analysis 
Image analysis was done using NIH ImageJ. The background for all conditions was 
determined as; mean intensity (AU) + 3*standard deviation of 3 randomly chosen GFP 
negative cells per field of view. The highest background value (among all conditions) was 
used as threshold for all the conditions. GFP positive cells (from Piezo2-GST IRES GFP 
expression) were chosen for each field of view and the PLA signal was analyzed for 
these cells, using the “Analyze Particle” tool of NIH ImageJ. The number of PLA puncta, 
intensity of the PLA signal and total area of positive PLA signal for each cell was 
measured. The total area of the cell was also measured and the PLA signal values were 
normalized to total cell area. All values are reported as mean ± SEM. For statistical 
analysis, either Mann Whitney test or Kruskal-Wallis test with Dunns’s Multiple 
Comparison Test was used as indicated in the figure legends (GraphPad Prism 6.01, San 
Diego). 
2.2. Functional characterization of interactors 
2.2.1. DRG culture and transfection 
The DRG culture protocol was adapted from Coste et al. (2010) and Avenali et al. (2014). 
8-9 week old male C57BL/6J mice or Piezo2GFP (Woo et al., 2014) were used for 
preparing primary cultures of dorsal root ganglia neurons. All DRGs were isolated from 
the mouse and transferred to DMEM/F12 with Glutamax. The tissue was digested with 
collagenase for 60 minutes followed by papain for 30 minutes at 37°C. The digested cells 
were subjected to a BSA column to separate the cells from debris. The cells were then 
re-suspended in DMEM/F12 Glutamax media supplemented with 10% horse serum and 
100 ng/ml NGF, 50 ng/ml GDNF, 50 ng/ml NT-3 and 50 ng/ml NT-4. Cells were plated on 
coverslips coated with poly-D-lysine (1mg/mL) and laminin (20 µg/ml).     
Neurons were transfected with siRNA or plasmid (siRNA: 500nM, plasmids: 0.5µg), with 
appropriate controls, using the P3 Primary Cell 4D Nucleofector X Kit; 4D-Nucleofector X 
Unit according to the manufacturer’s instructions (Lonza AG). Transfection was done 
after the BSA column step and the neurons were allowed to recover for 10 minutes in 
calcium free RPMI media before being plated. 2 hours after transfection, half of the media 
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was exchanged with fresh media containing growth factors. Details of the plasmids and 
siRNA used in the study are provided in supplementary table 1 and table 3 respectively. 
2.2.2. Quantitative PCR 
Total RNA was isolated from primary cultures of DRG neurons (transfected with 
candidate siRNA or control siRNA), using the NucleoSpin RNA XS kit according to the 
manufacturer's instructions. First-strand cDNA synthesis was carried out using 
QuantiTect reverse transcription kit. Primers for each gene were designed using the 
Universal ProbeLibrary Assay Design Center (Roche). The list of primers used in this 
study is provided in supplementary table 4. Gene expression of candidate and Piezo2 
were assessed by real-time qPCR using the SYBR green system (Power SYBR Green 
PCR Master Mix). Samples were input into 386 well plates (2µL cDNA (~1-100ng), 
100mM primer (forward and reverse) and 1X SYBR Green master mix). The 
measurements were done on a LightCycler 480 instrument (Roche). The melting curve 
analysis was used to confirm the specificity of the qPCR reaction. All samples were run in 
triplicate and the negative control reactions were run without template and with the 
reverse transcription reaction reagents. Threshold cycle (Ct) values, the cycle number in 
which SYBR green fluorescence rises above background, were normalized to two 
reference genes (β-actin and GAPDH) and recorded as a measure of initial transcript 
amount. Relative quantification was performed using the ‘fit point’ and the ‘second 
derivative maximum’ method of the LightCycler 480. For statistical analysis, one sample 
t-test was used (GraphPad Prism 6.01, San Diego). 
2.2.3. Cloning 
Cloning of Pericentrin from mouse tissue 
Total RNA was isolated from C57BL/6J mouse brain using the NucleoSpin RNA XS kit. 
OneTaq One-Step RT-PCR Kit was used to reverse transcribe the RNA into cDNA. The 
8.7Kb full length construct was amplified as two smaller fragments of 3.9Kb and 4.8 Kb. 
As a template for the cloning, sequence was obtained from NCBI (Nucleotide [Internet]. 
Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology 
Information; [1988]. Accession No. NM_008787.3, Mus musculus Pericentrin (kendrin) 
(Pcnt), transcript variant 1, mRNA; Available from: 
https://www.ncbi.nlm.nih.gov/nuccore/NM_008787.3). For the amplification PCR, primers 
were designed to contain EcoRV restriction site at the 5’ end of the 3.9Kb fragment and a 
Spe1 restriction site at the 3’ site of the 4.9Kb fragment (sequence provided in 
supplementary table 4). Each fragment was then introduced into a pGEM-T easy vector 
M E T H O D S  | 35 
 
and transformed into library efficiency DH5α cells and grown overnight at 37°C on 
Ampicillin containing plates. From the positively identified clones, the clones without 
significant mutations were identified using sequencing (compared to MN_08787.3 as 
described above). Any mutations that were identified were corrected using the Q5 Site-
directed mutagenesis kit. The two fragments were finally cloned into pCMV Sport6, a 
mammalian expression vector. The expression of the plasmid was verified using 
immunostainings in HEK293 cells.  
Cloning of Mtmr2 C417S enzymatically inactive mutant 
The Mtmr2C417S mutation was first described in Berger et al. (2002) as an catalytically 
inactivating mutation in mouse Mtmr2. pCMV Mtmr2-myc-DDK construct was used as 
template to generate the C417S mutant. Q5 site-directed mutagenesis kit was used to 
introduce a single nucleotide mutation. Primers were designed using the Q5 mutagenesis 
primer design software (New England Biolabs), and mutagenesis was done according to 
manufacturer’s instruction. A 200bp region was sequenced to ensure that only the 
desired mutation was introduced. The mutated region was then cloned into the wild-type 
construct, to avoid the chances of mutations in the other regions of the construct. The 
expression of the plasmid was verified using immunostaining in HEK293 cells. Details of 
the primer are provided in supplementary table 4.     
2.2.4. Immunocytochemistry 
Experimental methods 
Coverslips containing HEK293 cells or primary cultures of DRG neurons were washed 
with 1X PBS and fixed with 4% PFA for 10 minutes at room temperature. The cells were 
then incubated with blocking solution (3% serum, 0.4% TritonX-100 in 1X PBS) for 30 
minutes at room temperature. Following this, the cells were incubated with primary 
antibody solution (primary antibody diluted in 1% serum, 0.1% Triton-100 in 1X PBS), 
overnight at 4°C with mild shaking. After the overnight incubation, cells were washed with 
1X PBS over 15 minutes with gentle shaking. The cells were then incubated with the 
secondary antibody solution for 2 hours at room temperature. The cells were then 
washed again with 1X PBS and mounted with Slowfade Gold antifade reagent with DAPI 
and allowed to dry before imaging. WGA (Wheat Germ Agglutinin) staining to delineate 
the neuronal membrane was performed by incubation of neurons with WGA-coupled to 
Alexa555 for 15 minutes at 37°C. Cells were then washed three times with neuronal 
medium, fixed with 4% PFA for 10 minutes, and subjected to the immunostaining protocol 
as described above. Antibodies used in this study are listed in supplementary table 2.  
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Image acquisition 
The slides were imaged using either the Zeiss Axio Observer Z1 inverted microscope or 
a Zeiss 510 meta confocal laser scanning microscope (CLSM). 10X, 20X air objectives of 
40X oil objective was used. The imaging was always done keeping conditions constant 
for samples from the same experiments. Secondary controls were always imaged using 
the same conditions as samples.  
Analysis 
All image analysis was done using NIH ImageJ. To identify the positive cells, threshold 
was determined as; mean intensity (AU) + 3*standard deviation of 10 randomly chosen 
negative cells. For siRNA experiments, the “cell counter” tool was used to count positive 
and negative cells in each condition. The “analyze particle tool” from NIH ImageJ was 
used for quantification of membrane staining intensity. The WGA staining was used to 
mark the region of interest (ROI) around the cell membrane and for each ROI, the mean 
intensity of positive signal and mean area of positive signal was determined. For analysis 
of neuronal regions close to the cells substrate interface, the first five optical sections of 
each image were used and analysis was done as for the whole cells. For statistical 
analysis, the Mann Whitney test was used (GraphPad Prism 6.01, San Diego). 
2.2.5. Peptide-peptide/-lipid overlay assay 
Peptide-lipid assay protocol and peptide-peptide overlay assay was adapted from Berger 
et al. (2002) and Walsh et al. (2012) respectively, with minor modifications. Nitrocellulose 
membrane or PIP Strips were used for these assays. For the peptide-peptide overlay 
assay, 0.8µg of peptide (diluted in dH2O or 1X PBS) was spotted on the membrane and 
allowed to dry for 90 minutes at room temperature, in a humidified chamber. For the 
peptide-lipid overlay assay, PIP strips were washed once with PBS-T (1X PBS + 1% 
Tween-20). The protocol that follows, were common to both assays. The membranes 
were blocked with 3% fat-free BSA for 1 hour at room temperature. Membranes were 
then incubated with 5µg/mL peptide solution (diluted in 1% fat-free BSA) for 2 hours at 
room temperature with gentle shaking. After this, membranes were washed thrice with 
PBS-T for 7 minutes each and probed with primary antibody (diluted in 1% fat free BSA) 
for 2 hours at room temperature. Following which the membranes were washed with 
PBS-T three times shortly and three times for 5 minutes each. Membranes were then 
probed with secondary antibody for 1 hour at room temperature and then washed again 
as described above. Membranes were imaged using the Odyssey Infrared System (LI-
COR). A list of all peptides used in this study is provided in supplementary table 5.  
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2.2.6. Electrophysiology 
Whole-cell voltage clamp recordings were performed in transfected DRG neurons or 
HEK293 cells at room temperature. The cells were clamped at -70 mV for recordings of 
MA currents. Capacitance compensation was done at 60% and cells were considered for 
analysis only if their series resistance was lower than 10 MΩ.  
To measure MA currents (protocol adopted from Coste et al. (2010); Figure 9), cells 
were stimulated mechanically with a blunt glass probe (fire polished borosilicate glass 
capillary). The stimulation was delivered using a piezo-electrically driven 
micromanipulator (Physik Instrumente GmBH&Co. KG). The probe was positioned 4µm 
away from the cell membrane at the start of the protocol. The probe velocity was 
0.8µm/ms during the ramp phase (forward) and the stimulus duration was set to 150ms to 
allow complete adaptation/inactivation of the channels. The inter-stimulus interval was 
180 ms. Stimulus response curves were performed using mechanical stimuli from 0 to 
6µm in 1µm increments, and recording elicited currents at a holding potential of -70mV.  
All recordings other than those specifically indicated were made in standard extracellular 
solution containing (in mM) 127 NaCl, 3 KCl, 1 MgCl2, 2.5 CaCl2, 10 Glucose and 10 
HEPES, pH=7.3, osmolarity=285 mOsm. The intracellular solution for DRG neurons 
contained (in mM) 133 CsCl, 10 HEPES, 5 EGTA, 1 MgCl2, 1 CaCl2, 4 MgATP and 0.4 
NaGTP, pH=7.3, osmolarity=280 mOsm. Intracellular solution for HEK293 cells contained 
(in mM) 110 KCl, 10 NaCl, 1 MgCl2, 1 EGTA and 10 HEPES, pH=7.3, osmolarity=220 
mOsm.   
 
 
 
 
 
 
 
 
Figure 9: Illustration depicting recording of MA currents 
Schematic illustration showing the set-up for recording of MA currents. The cells are plated on poly-D-lysine 
coated coverslips and cultured for 48-72 hours. During the recording the cells are perfused with extracellular 
solution. Patch pipette filled with intracellular solution is used to patch the cell and enter whole cell mode 
(patch pipette shown on the left; holding voltage -70mV). Cells are stimulated using a piezo-electrically 
driven blunt mechanical probe (shown on the right) to elicit MA currents. (Adapted from Hao and Delmas 
(2011)) 
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Measurement of MA currents under different osmotic condition 
Hypotonic extracellular solution was prepared by diluting regular CsCl extracellular 
solution with ddH2O to 0.5X concentration. Based on data from Jia et al. (2016) the 
following protocol was used for recordings. Cells were incubated with the hypotonic 
solution for 5 minutes at 37°C prior to recording, after which RA-MA currents were 
recorded for 20 minutes. For osmotically different intracellular solutions, the solutions 
were introduced in the patch pipette instead of the isotonic intracellular solution and RA-
MA currents were recorded. Hypertonic intracellular solution (in mM): 133 CsCl, 10 
HEPES, 5 EGTA, 1 MgCl2, 1 CaCl2, 4 MgATP, 0.4 NaGTP and 120 Sucrose, pH=7.3, 
osmolarity=390 mOsm. Hypotonic intracellular solution (in mM): 65 CsCl, 10 HEPES, 5 
EGTA, 1 MgCl2, 1 CaCl2, 4 MgATP and 0.4 NaGTP pH=7.3, osmolarity=162 mOsm. 
Pharmacological modulation of MA currents 
During the study, primary cultures of DRG neurons were treated with chemical inhibitors 
to study the modulation of RA-MA currents. For Nocodazole treatment, cells were 
incubated with 32µM Nocodazole or vehicle (0.2% DMSO) (adapted from Jurczyk et al. 
(2010)) for 30 minutes prior to recording. During the whole-cell recordings of RA-MA 
currents, 32µM Nocodazole/DMSO was also added to the internal pipette solution. For 
treatment of DRG neurons with inhibitors of phosphatidylinositol pathway, cells were 
treated with 35µM Wortmannin in DMSO (adapted from Mo et al. (2009)) or 1µM Apilimod 
in DMSO (adapted from Mironova et al. (2016)) for 2 hours prior to recording and 
recorded using normal extra and intracellular solutions (DMSO only (0.35% for 
Wortmannin and 0.08% for Apilimod), control was included in all experiments). For 
phosphatidylinositol phosphate supplementation experiments, 100nM, 1µM or 10µM 
PI(3,5)P2 or 1µM PI(3)P were included in the intracellular CsCl solution (adapted from 
Dong et al. (2010)). 
Analysis 
Analysis protocol was adopted from Coste et al. (2010) and Eijkelkamp et al. (2013). 
Data analysis and representation was done using using Fitmaster (HEKA Electronik 
GmbH, Germany) and Igor Pro 6.3 (WaveMetrics). Current magnitude was calculated by 
measuring peak amplitude (at each stimulus point) and subtracting leak current. To 
account for variability in cell size, currents were normalized to cell capacitance and 
represented as current density (pA/pF). For measurement of inactivation kinetics, current 
traces reaching at least 75% of the maximal current amplitude per cell were fitted with 
mono-exponential or bi-exponential equation and the fast time constant was used for 
analysis. 
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For analysis of Stim50, current density was normalized to maximum current to obtain 
normalized values ranging from 0 to 1. The data was fit using the sigmoidal equation: 
I0+ Imax/(1+ exp(S1/2-S)/(rate)), where I0 represents minimum current, Imax represents 
maximum current, S1/2 represents stimulation value that elicited a current value, 50% of 
Imax (as described in Hao et al. (2013)). Values are reported as mean ± SEM of all 
analyzed cells. (Only cells that responded to the maximum stimulus magnitude (6 µm) 
were considered for this analysis). 
For activation threshold analysis, the stimulus magnitude at which current density 
crossed 10% of Imax of control was measured (adapted from Eijkelkamp et al. (2013)). 
Data are represented as mean ± SEM. 
For statistical analysis, outlier analysis was carried out using Grubb’s t-test followed by 
verification using mean+3*standard deviation criterion. Only if a value was detected as an 
outlier by both these (Grubb’s outlier and >mean+3*standard deviation) tests it was 
considered a bona fide outlier and removed from the data set. For analysis of stimulus-
current curves, 2-way ANOVA with Holm-Sidak’s post hoc test was employed. For 
analysis of activation threshold, Stim50 and inactivation time, Mann Whitney test or 1-way 
ANOVA (Kruskal-Wallis test with Dunn’s Multiple Comparison test) was used. Chi square 
test was used for the analysis of population distribution of MA currents (GraphPad Prism 
6.01, San Diego).   
It is important to note that current magnitudes and activation thresholds cannot be 
compared between experiments because recordings of MA currents were done on 
different days in vitro (DIV) and cells were subjected to different treatments, transfections 
etc. Keeping this in mind each experiment was performed with its appropriate controls.  
2.2.7. Behavioral testing 
Behavioral testing was performed by Meike Hütte (Somatosensory signaling and 
Systems biology group, Max Planck Institute for Experimental medicine). 9-10 week old 
C57BL/6 mice were used for these experiments. The experiments were carried out in 
compliance with institutional guidelines of the Max Planck Society and guidelines of the 
Landesamt für Verbraucherschutz und Lebensmittelsicherheit of Lower Saxony, 
Germany (AZ 33.9-42502-04-14/1638). The animals were acclimatized for 2 hours in the 
testing device (Plantar Aesthesiometer, Ugo Basile) and then injected subcutaneously 
into the midplanter region of the left hind paw. 10µL of the respective experimental agent 
was injected.   
Experimental agents used: Apilimod (Cayman Chemical; stock solution: 20µg/µL 
dissolved in DMSO; diluted 1:100 in 1X PBS to a working concentration of 0.2µg/µL), 
vehicle (1% DMSO in 1X PBS), hypo osmotic solution (0.5X PBS, osmolarity= 155 
40 |  M E T H O D S  
 
mOsm; Of note, 1X PBS, osmolarity=270-300 mOsm (ThermoFisher Scientific)), Apilimod 
in hypo osmotic solution (stock solution: 20µg/µL dissolved in DMSO; diluted 1:100 in 
0.5X PBS (155 mOsm) to a working concentration of 0.2µg/µL).  
Response to innocuous mechanical stimulation, was measured using a Plantar 
Aesthesiometer (Ugo Basile) by applying a graded force (0-10 g in 40 seconds) to the 
plantar surface of the hind paw. Measurements were made between 0-90 minutes after 
the injection. Three independent measurements were made per paw and an average of 
these values was used to calculate withdrawal thresholds (force, g) and withdrawal 
latencies (time, seconds). Comparison was always made between the ipsilateral 
(injected) paw and the contralateral (un-injected) paw. This accounted for changes in the 
animal’s arousal and stress caused by the unilateral injection. Three independent mouse 
cohorts were used for the experiments.  
Statistics 
Data was analyzed using GraphPad Prism 6.01. For analysis of reduction in withdrawal 
threshold and average withdrawal threshold, 2-way ANOVA followed by Holm-Sidak’s 
post hoc tests were used.  
R E S U L T S :  P A R T  1  | 41 
 
3. RESULTS: Part 1 
A large part of the results in this section are based on Narayanan et al. (2016). Reprinted 
(adapted) with permission from Narayanan et al. (2016). Copyright (2016) American 
Chemical Society. 
3.1. Verification of Piezo2-Pericentrin (Pcnt) interaction as proof of principle 
Since the identification of Piezo2, its function and modulation have been of great interest. 
In order to systematically identify the interactors of Piezo2, in 2016 our lab reported an 
affinity purification based approach to identify novel interactors of native Piezo2 from 
DRG neurons in mice (Narayanan et al., 2016). Figure 5 illustrates the outline of the 
experimental approach used towards this goal. Through this screen, 36 potential 
interactors of mouse Piezo2 in DRG neurons were identified. Figure 6 summarizes the 
results obtained from this part of the study (Narayanan et al., 2016). After the 
identification of potential interactors, the first step was to assess the robustness of the 
screen using orthogonal methods. For this purpose a candidate protein, identified on our 
screen as significant (p=0.022, unpaired t-test) but low score interactor was chosen. It 
exhibited a moderate fold change (3.6-fold enriched compared to control) and 
represented a highly unlikely interactor of Piezo2, namely Pericentrin (Pcnt). Pcnt is 
expressed across tissues and cells and is known for its centrosomal localization and role 
in cell-cycle regulation and microtubule organization (Delaval and Doxsey, 2010). 
Additional roles for Pcnt have been described in the visual and olfactory system (Endoh-
Yamagami et al., 2010; Miyoshi et al., 2009; Mühlhans et al., 2011). Interestingly, Pcnt is 
linked to mechanotransduction in the Drosophila mechanosensory system. Loss of Pcnt 
causes mechanosensory deficits in the fly, through malformation of sensory cilia 
(Martinez-Campos et al., 2004).   
3.1.1. Piezo2 and Pericentrin (Pcnt) co-immunoprecipitate, in HEK293 cells 
To validate the mass-spectrometry results, co-immunoprecipitation was done as 
described in the methods section (2.1.2). I co-expressed Piezo2-GST and Pcnt in 
HEK293 cells. Anti-GST antibody was used to pull down Piezo2 from the cells and the 
elute (IP) and cell lysate fractions were resolved using gel electrophoresis and western 
blotting. The blots were probed with anti-Pcnt antibody and anti-GST antibody. Pcnt was 
identified in the elute fraction when overexpressed with Piezo2-GST but not with mock 
plasmid (Figure 10A). Importantly, anti-Pcnt antibody identified Pcnt in the lysate of 
Piezo2+Pcnt and Mock+Pcnt. This indicates that a) Pcnt can be successfully 
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overexpressed in HEK293 cells and b) when co-expressed with Piezo2, it forms an 
association with the channel and can be co-immunoprecipitated with it. Figure 10B 
illustrates that Piezo2-GST was also identified in the elute fraction (IP) when Pcnt and 
Piezo2 are co-expressed. Lack of Piezo2 signal in the cell lysate could be due to the 
higher dilution of the lysate and/or low expression of Piezo2. Of note, the anti-Pcnt 
antibody was validated through siRNA mediated knockdown experiments before being 
used for the immunoblotting (data in following sections).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Co-immunoprecipitation (IP) of Piezo2 and Pericentrin in HEK293 cells 
Representative immunoblots of Piezo2-GST and Pcnt co-immunoprecipitation in HEK293 cells. (A) anti-GST 
antibody was used to pulldown Piezo2-GST from HEK293 cells. Piezo2 was  co-expressed with either Pcnt 
or Mock plasmid. Upon co-expression with Pericentrin, anti-Pcnt antibody detects Pcnt in the IP 
(immunopurified product; arrowhead) indicating that Pcnt is pulled down with Piezo2.  In case of co-
expression with mock, however, Pcnt can only be identified in the cell-lysate (arrows) but not in the 
immunopurified product (IP; *)). (B) Piezo2 is observed in elute (IP) of HEK293 cells expressing Piezo2 and 
Pericentrin (arrows) but not in Mock+Pcnt. This indicates that Piezo2-GST is expressed in HEK293 cells and 
can be immunoprecipitated with the anti-GST antibody. Blots were repeated at least three times. Reprinted 
(adapted) with permission from Narayanan et al. (2016). Copyright (2016) American Chemical Society. 
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3.1.2. Pericentrin (Pcnt) is expressed in the somatosensory system 
Pericentrin is expressed in peripheral nerve endings 
In order to characterize Pcnt expression in the somatosensory system, I used tissue from 
Piezo2GFP mice which expresses Piezo2 tagged with a C-terminal GFP (Woo et al., 
2014). This allows for immunolabelling of Piezo2 using the anti-GFP antibody. Of note, 
the Piezo2 antibody that was tested positive during the mass-spectrometry experiments 
(section 1.3.4) did not work well in the immunohistochemistry experiments. In order to 
gain reliable insights into the localization of Piezo2, the GFP immunolabelling approach 
was used instead. 
It is known that Piezo2 is expressed in LTMRs in the backskin of mice (Ikeda et al., 2014; 
Maksimovic et al., 2014; Ranade et al., 2014; Schrenk-Siemens et al., 2014; Woo et al., 
2014). Based on this, expression of Pcnt was analyzed in the same structures. Indeed, in 
cross-sections of the back hairy skin from mice, I observed Pcnt staining in nerve fibers 
innervating hair follicles. The staining was observed in both lanceolate (arrows in Figure 
11A) and circumferential endings (arrowheads in Figure 11A) (Abraira and Ginty, 2013; 
Li and Ginty, 2014; Shenton et al., 2014). Interestingly, some of the Pcnt label co-
localized with the Piezo2-GFP staining while some of it appeared to be in closed 
apposition with Piezo2. Co-staining with Tuj1 (neuronal marker), also showed that Pcnt is 
expressed in neuronal structures or at least in close apposition with them (Figure 11A, 
upper panel). Additionally, lower panel of Figure 11A shows that Pcnt immunolabel also 
appears to be in close apposition with the Schwann cell marker, S100 (Li and Ginty, 
2014; Shenton et al., 2014) immunolabel. This novel localization of Pcnt is interesting 
because so far Pcnt has only been reported in cell bodies and primary cilia (Delaval and 
Doxsey, 2010). A major limitation of these experiments arises from the structure of these 
terminals. The nerve endings innervating the hair follicle are tightly engulfed by terminal 
Schwann cells. Thus, resolution of conventional light microscopy proved insufficient to 
localize Pcnt precisely in these structures (Li and Ginty, 2014; Shenton et al., 2014).   
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Figure 11: Pericentrin expression in the mammalian somatosensory system  
(A) Upper and lower panel show representative immunohistochemistry images from the cross section of 
back skin from Piezo2
GFP 
mice showing the innervation of hair follicle by Piezo2 positive fibers. Piezo2-GFP 
is identified in the lanceolate (arrows) and circumferential endings (arrowheads) that innervate the hair 
follicles. Immunolabelling against Pcnt shows significant overlap or apposition with the Piezo2-GFP staining. 
Pcnt also shows considerable overlap/apposition with Tuj1 (neuronal marker). Bottom panel shows 
magnified images of the upper panel showing the close apposition of Pcnt with Piezo2-GFP and the S100 
immunolabel in lanceolate endings (arrow); N> 3 for each immunolabel. (B) Representative 
immunohistochemistry and (D) immunocytochemistry of Pcnt immunolabel in cell bodies of dorsal root 
ganglia (DRG neurons) in tissue and primary culture (from Piezo2
GFP
 mice) respectively. Pcnt is seen as a 
centrosomal puncta as well as dispersed staining in the cytoplasm of Piezo2 positive (arrows) and Piezo2 
negative neurons (arrowheads). (C) and (E) quantification of Pcnt immunolabel in Piezo2 positive and 
Piezo2 negative neurons in DRG tissue and primary culture, respectively. Pcnt immunolabel shows no 
significant differences between the two populations of neurons (Immunohistochemistry: Pcnt in Piezo2 
positive cells: 91.5 ± 2.36%; Pcnt in Piezo2 negative cells: 84.6 ± 5.37%; n>2000 neurons; ns; unpaired t-
test; Immunocytochemistry: Pcnt in Piezo2 positive cells: 91.0 ± 2.38%; Pcnt in Piezo2 negative cells: 84.0 ± 
5.43%; n=304 neurons; ns; unpaired t-test). Scale bars: 10µm (A); 25µm (B,D). Reprinted (adapted) with 
permission from Narayanan et al. (2016). Copyright (2016) American Chemical Society. *: p<0.05; **: 
p<0.01; ***: p<0.0001; ****: p<0.00001; data are not significant unless otherwise stated. 
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Pericentrin is expressed in cell bodies of DRG neurons 
Due to the difficulties of resolving the structural details in the peripheral nerve endings, I 
tested the anti-Pcnt antibody in cell bodies of DRG neurons. Two commercial Pcnt 
antibodies were tested, which have been used extensively in literature (Griffith et al., 
2008; Miyoshi et al., 2006; Miyoshi et al., 2009; Mühlhans et al., 2011; Mühlhans and 
Gießl, 2012; Zu et al., 2015).   
Consistent with the above mentioned studies, Pcnt was found as a distinct centrosomal 
puncta as well as smaller puncta throughout the cytoplasm. Figure 11B shows 
representative images of Pcnt and GFP staining in DRG tissue from Piezo2GFP mice. In 
order to test if Pcnt distribution in the DRG neurons was related to Piezo2 positivity of the 
cells, the number of Pcnt positive neurons in Piezo2 positive and Piezo2 negative 
populations were counted. I found no significant difference in the Pcnt expressing cells 
among the two populations (unpaired t-test; Figure 11C).  
Similar results were obtained when DRG cultures prepared from the Piezo2GFP mice were 
analyzed (unpaired t-test; Figure 11D and E). Interestingly, this data is supported by a 
recent study using RNA-seq analysis of DRG neurons. The study showed that Pcnt is 
ubiquitously expressed in the different DRG neuron populations (Usoskin et al., 2015). 
Piezo2 and Pericentrin are expressed in close proximity in DRG neurons 
After the identification of Pcnt in the somatosensory system, the next step was to study 
its expression in the cell in relation to Piezo2. Towards this aim, proximity ligation assay 
(PLA) was used (Söderberg et al., 2006). In PLA, primary antibodies are used to detect 
the proteins of interest which are then probed by a secondary antibody coupled with 
oligonucleotide strands. If the two proteins are at distance, maximum of 40nm apart, the 
oligonucleotides participate in a rolling circle DNA synthesis which amplifies the signal 
several hundred-fold. This signal can then be detected by fluorescently labelled 
complimentary oligonucleotide probes. The result is a distinct fluorescent puncta 
indicating a point of interaction of the two proteins which can be visualized with 
fluorescence microscopy. In DRG neurons, this technique has been successfully used to 
demonstrate TRPV1-GABAB interaction (Hanack et al., 2015).  
To test proximity of Piezo2 and Pcnt, DRG cultures prepared from Piezo2GFP mice were 
used. Primary antibodies against GFP and Pcnt were used to detect the proteins of 
interest. As mentioned in the previous section, the anti-Piezo2 antibody was found to be 
unreliable in immunostainings and hence was not used for these experiments. Using anti-
GFP and anti-Pcnt antibodies, a robust PLA signal was observed (Figure 12A) while the 
no specific signal was observed upon omission of either antibody (results shown for 
omission of anti-Pcnt antibody).The number of PLA puncta/neuron was analyzed to 
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provide a quantitative measure of the assay. The number of puncta/neuron was 
significantly higher when both antibodies were used compared to omission of either 
antibody (Mann Whitney test; Figure 12B). These results indicate that Pcnt and Piezo2-
GFP are indeed localized in close proximity to each other (maximally 40nm apart) in DRG 
neurons. These results prompted the question; what does this proximity of Piezo2 and 
Pcnt mean for the function of the channel? 
 
 
 
 
 
 
 
 
 
3.2. Functional characterization of Piezo2-Pericentrin (Pcnt) interaction in 
DRG neurons 
In order to understand how Pcnt may influence Piezo2 channel function, I used DRG 
cultures from mice as the model system. The DRG cultures provide an ideal system for 
targeted manipulation of protein levels and assessment of Piezo2 function. Of note, 
Piezo2 was first described in the DRG cultures system (Coste et al., 2010).  
Pericentrin siRNA decreases Pcnt mRNA and protein levels in DRG neurons  
To study the relevance of Pcnt for Piezo2 function, I used nucleofection to transfect DRG 
neurons with siRNA against Pcnt. As control, non-targetting siRNA (CTRL) was 
transfected. The details of the transfection are described in the methods section (2.2.1). 
Cells were maintained in culture for 72 hours prior to analysis. In order to quantify the 
Figure 12: Piezo2 and Pericentrin express in close proximity in DRG neurons 
Representative images (A) and quantification (B) of proximity ligation assay (PLA) in DRG neurons cultured 
from Piezo2
GFP
 mice. Anti-GFP and anti-Pcnt antibodies were used to detect Piezo2 and Pericentrin 
respectively. Robust PLA signal is seen when both antibodies are used, while omission of either antibody 
(CTRL; shown here for omission of anti-Pcnt antibody) results in a significant decrease of the PLA signal 
(anti-GFP + anti-Pcnt: 39 ± 7 puncta/neuron; only anti-GFP: 14 ± 2 puncta/neuron; n=32-65 neurons per 
condition; p=0.0012; Mann Whitney test; the number of punta were rounded off to the nearest whole 
number). Scale bar=25µm. Reprinted (adapted) with permission from Narayanan et al. (2016). Copyright 
(2016) American Chemical Society. *: p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are not 
significant unless otherwise stated.    
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knockdown of Pcnt upon siRNA transfection in DRG neurons, real-time quantitative PCR 
was used as described in the methods section (2.2.2). Pcnt mRNA was significantly 
reduced in Pcnt siRNA transfected cells (Pcnt siRNA) compared to control transfected 
cells (CTRL). This was measured relative to two housekeeping genes β-actin and 
GAPDH (one sample t-test; Figure 13A). To check if Piezo2 is changed upon Pcnt 
knockdown, Piezo2 mRNA was also measured in these cultures. No significant difference 
was observed in Piezo2 mRNA upon Pcnt knockdown (one sample t-test; Figure 13B). 
The results show that Pcnt siRNA was successful in knocking down Pcnt in DRG neurons 
without affecting Piezo2 mRNA levels. 
Besides mRNA levels, I also quantified protein levels of Pcnt upon knockdown using 
immunostaining. Figure 13C shows representative immunostaining of Pcnt in DRG 
neurons upon transfection with non-targeting siRNA (CTRL) or Pcnt siRNA. The number 
of Pcnt positive cells was found to be significantly decreased upon siRNA knockdown of 
Pcnt (unpaired t-test; Figure 13D). Importantly, in Pcnt negative cells, both centrosomal 
and cytoplasmic Pcnt staining was either entirely absent or significantly reduced in 
intensity compared to Pcnt positive cells. The results, besides confirming that Pcnt siRNA 
successfully decreases Pcnt protein expression also confirm the specificity of the Pcnt 
antibodies (results were comparable for both Pcnt antibodies tested; Abcam and 
Covance).  
  
 
 
 
 
 
 
 
 
Figure 13: Knockdown of Pericentrin in DRG neurons 
Quantification of Pcnt mRNA under control (CTRL) and Pcnt siRNA condition (A) shows a significant 
decrease in the Pcnt mRNA under siRNA condition compared to CTRL (shown for actin as reference 
housekeeping gene (Pcnt siRNA, actin as reference: 0.31 ± 0.11; N=5 cultures; p=0.0036; one sample t-test 
(compared to a theoretical mean of 1.00 (CTRL)). Of note, similar results were obtained when using GAPDH 
as reference (data not shown). Quantification of Piezo2 mRNA upon Pcnt knockdown (B) shows no 
significant difference between CTRL and Pcnt siRNA (Pcnt siRNA, actin as reference: 1.14 ± 0.22; N=5 
cultures; ns; one sample t-test (compared to a theoretical mean of 1.00 (CTRL)). Similar results were 
obtained when using GAPDH as reference (data not shown). Representative images (C) and quantification 
(D) of the Pcnt immunolabel in DRG neurons upon Pcnt knockdown. Pcnt signal was significantly reduced 
from both centrosomes and cytoplasm, upon treatment with Pcnt siRNA (Pcnt positive cells in CTRL: 92.70 
± 0.94%; Pcnt positive cells in Pcnt siRNA: 47.60 ± 2.87%; N=14 cultures and n>1000 neurons; p<0.0001; 
unpaired t-test). Scale bar=15µm. Reprinted (adapted) with permission from Narayanan et al. (2016). 
Copyright (2016) American Chemical Society. *: p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are 
not significant unless otherwise stated. 
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3.2.1. Pericentrin (Pcnt) knockdown potentiates Piezo2 mediated MA currents 
To study the effect of Pcnt knockdown in DRG neurons on Piezo2, the most direct 
method is to measure Piezo2 mediated RA-MA currents. As described in the methods 
section (2.2.6), whole cell patch-clamp coupled with mechanical stimulation was used to 
measure Piezo2 MA currents.  
In brief, large diameter DRG neurons were stimulated with a blunt glass probe while 
whole cell MA currents were recorded (as sown in Figure 9). Large diameter neurons 
were chosen because these are known to exhibit Piezo2 mediated currents (Coste et al., 
2010). MA currents were measured 72 hours after siRNA transfection. Figure 14A shows 
representative current traces obtained from CTRL or Pcnt siRNA treated neurons. As can 
be clearly seen, upon Pcnt knockdown, there is a significant increase in the Piezo2 
mediated RA-MA.  
This is quantified in the stimulus-current curves (2-way ANOVA and post hoc Bonferroni 
test; Figure 14B). I also measured the activation threshold of the whole cell RA-MA 
currents upon Pcnt knockdown. This is defined as the stimulus required to elicit a 
minimum discernable current (in our case defined at 10% of Imax of CTRL currents). The 
activation threshold of Pcnt siRNA treated cells was significantly reduced, which 
correlates with the increased current magnitude (unpaired t-test; Figure 14C). 
Additionally, another feature of RA-MA currents is the Stim50 (stimulus required to elicit 
50% of maximum current). This property remained unchanged upon Pcnt knockdown 
(unpaired t-test; Figure 14D). I also analyzed the inactivation time constant (τ) of the RA-
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MA currents and found no significant differences between CTRL and Pcnt siRNA 
(unpaired t-test; Figure 14E).  
The data indicate that loss of Pcnt potentiates Piezo2 mediated RA-MA currents. 
Importantly, the defining property of the RA-MA currents (namely the rapid inactivation) 
remains unaffected upon Pcnt knockdown. 
 
 
 
 
 
 
 
 
 
 
  
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Pericentrin knockdown in DRG neurons potentiates RA-MA currents 
Representative traces of RA-MA currents in CTRL and Pcnt siRNA treated DRG neurons (A). Stimulus-
current curves (B) show that Pcnt knockdown causes significant increase in the Piezo2 mediated RA-MA 
currents (n=50-52 neurons per conditions; 2-way ANOVA and post hoc Bonferroni test). Activation threshold 
(C) of RA-MA currents upon loss of Pericentrin is significantly lower than CTRL (CTRL: 4.09 ± 0.15 µm; Pcnt 
siRNA: 3.10 ± 0.15 µm; n=50-52 neurons per condition; p<0.0001; unpaired t-test). Stim50 of RA-MA 
currents (D) remains unchanged upon Pcnt knockdown (CTRL: 4.32 ± 0.08 µm; Pcnt siRNA: 4.32 ± 0.08 µm; 
n=50-52 neurons per condition; ns; unpaired t-test). Inactivation time constant (τ) of RA-MA currents (E) 
remains unchanged upon Pcnt knockdown (CTRL: 4.78 ± 0.28 ms; Pcnt siRNA: 4.29 ± 0.25 ms; n=50-52 
neurons per condition; ns; unpaired t-test). Reprinted (adapted) with permission from Narayanan et al. 
(2016). Copyright (2016) American Chemical Society. *: p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; 
data are not significant unless otherwise stated.  
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3.2.2. Pericentrin (Pcnt) knockdown does not affect other MA currents or 
population of MA currents 
As mentioned in the introduction, DRG neurons in mice exhibit three types of MA currents 
which can be distinguished based on their inactivation time constants (τ) (Coste et al., 
2010). The RA-MA currents are predominantly mediated by Piezo2 (Coste et al., 2010; 
Dubin et al., 2012; Ranade et al., 2014). While little is known about IA-MA currents, SA-
MA currents were recently shown to be mediated by Tentonin 3/TMEM150c (Hong et al., 
2016). In order to know if Pcnt knockdown affected other MA currents in DRG neurons, I 
recorded IA and SA-MA currents from neurons treated with Pcnt siRNA or CTRL. I found 
that neither IA-MA nor SA-MA currents were affected by Pcnt knockdown (Figure 15A 
and B). The stimulus-current curves show no differences in magnitude between 
conditions (2-way ANOVA and post hoc Bonferroni test; Figure 15A and B). The 
activation threshold of the IA-MA and SA-MA currents was also unchanged upon Pcnt 
knockdown, indicating that the influence of Pcnt was remarkably specific to Piezo2 RA-
MA currents (Activation threshold: IA-MA: CTRL: 2.47 ± 0.33 µm; Pcnt siRNA: 2.16 ± 
0.20 µm; ns; 17-18 neurons per condition; unpaired t-test; SA-MA: CTRL: 1.50 ± 0.50 µm; 
Pcnt siRNA: 1.28 ± 0.16 µm; ns; 7-8 neurons analyzed per condition; unpaired t-test).  
As mentioned above there are different types of MA currents in DRG neurons and each 
current type is exhibited by defined populations in the system. Considering, loss of Pcnt 
potentiates RA-MA currents; I wanted to check if the number of cells exhibiting these 
currents may also have been changed. As shown in Figure 15C, I did not observe any 
significant differences in the fractions of different MA current populations in cultures 
treated with CTRL of Pcnt siRNA (Fisher’s exact test; Figure 15C). The data is consistent 
with previously reported proportions of MA currents in DRG cultures (Coste et al., 2010).  
Therefore, it can be concluded that Pcnt knockdown exerts a very specific effect on 
Piezo2 RA-MA currents. It neither influences other MA currents nor the general 
properties of the culture system.  
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Figure 15: Pericentrin knockdown does not affect IA-MA and SA-MA currents 
Stimulus-current curves of IA (A) and SA (B)-MA currents under CTRL or Pcnt siRNA conditions show no 
significant differences (IA-MA: n=17-18 neurons per condition; ns; 2-way ANOVA with post hoc Bonferroni 
test; SA-MA: n=7-8 neurons per condition; ns; 2-way ANOVA with post hoc Bonferroni test). Population 
distribution of RA-MA, IA-MA, SA-MA and NR (non-responder) neurons in DRG cultures (C) treated with 
CTRL or Pcnt siRNA. The fraction of cells displaying the different mechanically activated currents remains 
unchanged upon Pcnt knockdown (RA:IA:SA:NR; CTRL: 0.37: 0.13: 0.06: 0.44; Pcnt siRNA: 0.43: 0.12: 
0.08: 0.38; n>200 neurons per condition, pooled data from Figure 14B, Figure 15A and B; ns; Fisher’s 
exact test). Reprinted (adapted) with permission from Narayanan et al. (2016). Copyright (2016) American 
Chemical Society. *: p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are not significant unless 
otherwise stated. 
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3.2.3. Pericentrin (Pcnt) overexpression in DRG neurons but not in HEK293 cells 
affects cell health  
Considering that the loss of Pcnt, potentiated Piezo2 RA-MA currents, the question arose 
whether overexpression of Pcnt would have the opposite effect. Unfortunately, in contrast 
to the siRNA transfected DRG neurons, neurons overexpressing Pcnt were severely 
compromised in terms of health. I observed significant blebbing in the Pcnt transfected 
neurons and also it was considerably more difficult to record MA currents from these 
neurons.  
Despite these issues, I recorded RA-MA currents from the few healthy cells, 48 hours 
after transfection. I found a significant reduction in the RA-MA currents, upon 
overexpression of Pcnt compared to overexpression of empty vector (2-way ANOVA and 
post hoc Bonferroni test; Figure 16A). The result is in line with what is expected based 
on the data (Figure 14B) obtained from the knockdown of Pcnt, but due to the 
compromised cell health, I refrain from interpreting these results.  
Since the cellular health was compromised by the overexpression of Pcnt in DRG 
neurons, I tested if overexpression in heterologous system could be used to study the 
Piezo2-Pcnt interaction. Piezo2 was co-expressed with mock plasmid (mock) or Pcnt in 
HEK293 cells. Cells were allowed to express the constructs for 48 hours before 
measuring Piezo2 mediated RA-MA currents. I did not observe any significant difference 
in Piezo2 RA-MA currents upon co-expression with mock or Pcnt (2-way ANOVA and 
post hoc Bonferroni test; Figure 16B). Note that Pcnt overexpression in HEK293 cells did 
not adversely affect cell health. The difference between DRG neurons and HEK293 cells 
could be explained by the compromised cell health in DRG neurons. There may also be a 
biological basis for the differences i.e. Pcnt may play different roles in post-mitotic DRG 
neurons compared to mitotic HEK293 cells (Buchman et al., 2010; Dammermann, 2002; 
Li et al., 2001; Zimmerman et al., 2004). Besides, the Piezo2-Pcnt interaction may 
require the presence of cell specific mediators that may be unavailable in HEK293 cells. 
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3.3. Mechanism of Piezo2-Pericentrin (Pcnt) interaction 
Membrane expression of Piezo2 is increased upon Pericentrin knockdown 
In order to examine the cause of RA-MA potentiation, I checked for the Piezo2 
expression upon loss of Pcnt. As shown in Figure 13B, mRNA of Piezo2 remains 
unchanged; hence membrane protein levels were tested. For this purpose, DRG neurons 
were cultured from the Piezo2GFP mice (Woo et al., 2014). The neurons were transfected 
with CTRL or Pcnt siRNA and maintained in culture for 72 hours prior to staining. To 
visualize the Piezo2 membrane levels, the cells were immunostained for GFP and WGA 
(Wheat germ agglutinin). WGA is a membrane dye that can be used to delineate cellular 
membranes, which facilitates the assessment of membrane Piezo2-GFP. Interestingly, I 
found a significant increase in the immunofluorescence of GFP on the membrane of the 
cells treated with Pcnt siRNA compared to CTRL (unpaired t-test; Figure 17A and B).  
Figure 16: Pericentrin overexpression in DRG neurons and HEK293 cells 
Stimulus-current curves of RA-MA currents upon overexpression of empty vector (mock) or Pericentrin 
plasmid in DRG neurons (A). Overexpression of Pcnt significantly decreases Piezo2 mediated RA-MA 
current magnitude (n=6-9 cells per condition; 2-way ANOVA with post hoc Bonferroni test). It is important to 
note here that cellular health was severely compromised upon Pcnt overexpression in DRG neurons. 
Stimulus-current curves for overexpression of Piezo2 and Pcnt in HEK293 cells (B). Co-expression of Pcnt 
does not influence Piezo2 RA-MA currents compared to co-expression with mock plasmid (n=26-27 neurons 
per condition; 2-way ANOVA with post hoc Bonferroni test). Reprinted (adapted) with permission from 
Narayanan et al. (2016). Copyright (2016) American Chemical Society. *: p<0.05; **: p<0.01; ***: p<0.0001; 
****: p<0.00001; data are not significant unless otherwise stated. 
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Further, Poole and colleagues have shown that Piezo2 function depends critically on its 
substrate interactions (Poole et al., 2014). This prompted the question whether the 
Piezo2-GFP signal that I observed over the complete cellular membrane was also 
enhanced at the cell-substrate interface, upon Pcnt knockdown. For this, I analyzed the 
first five optical sections of the imaged cells (region closest to substrate) and found a 
similar increase at the cell-substrate interface (unpaired t-test; Figure 17C).  
Figure 17: Exploring mechanisms of Piezo2-Pericentrin interaction 
Representative images (A) and quantification (B, C) of membrane expression of Piezo2-GFP upon Pcnt 
knockdown in DRG neurons. Piezo2-GFP membrane expression is significantly increased upon Pcnt 
knockdown (Piezo2-GFP membrane intensity in CTRL: 10.07 ± 0.50 AU; Pcnt siRNA: 11.46 ± 0.52 AU; n=50 
neurons per condition; p=0.0098; unpaired t-test). Membrane expression was also measured at cell-
substrate interface, where similar to whole cell membrane, Piezo2-GFP immunolabel is significantly 
increased in Pcnt knockdown DRG neurons (Piezo2-GFP membrane intensity in CTRL: 10.34 ± 0.51 AU; 
Pcnt siRNA: 11.79 ± 0.50 AU; n=50 neurons per condition; p=0.0089; unpaired t-test). Scale bar = 10µm. 
Stimulus-current curves for RA-MA currents (D) upon treatment of cells with anti-mitotic agent, Nocodazole 
(35µM). The treatment did not show any effect on RA-MA currents (n=12-16 neurons per condition; 2-way 
ANOVA and post hoc Bonferroni test). Reprinted (adapted) with permission from Narayanan et al. (2016). 
Copyright (2016) American Chemical Society. *: p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are 
not significant unless otherwise stated. 
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Nocodazole treatment does not affect Piezo2 RA-MA currents 
From the earlier experiments, it has been established that Pcnt knockdown in DRG 
neurons increases Piezo2 mediated RA-MA currents which is supported by an increased 
Piezo2-GFP membrane expression. Considering that there is no change in the Piezo2 
mRNA upon Pcnt knockdown, an increase in the trafficking of Piezo2 to the membrane is 
a likely scenario. From previous studies on Pcnt function, it is known that Pcnt is crucially 
involved in microtubule organization through its role in microtubule organization complex 
(MTOC) (Delaval and Doxsey, 2010). Based on this evidence, the Piezo2 phenotype 
upon Pcnt knockdown may be mediated by microtubule based transport. To test this, 
DRG neurons were treated with Nocodazole (Jurczyk et al., 2010) and Piezo2 mediated 
RA-MA currents were measured. Nocodazole is an anti-mitotic agent which disrupts 
microtubules by binding to β-tubulin. This in turn disrupts microtubule dynamics and has 
an effect on microtubule dependent trafficking. Surprisingly, microtubule disruption failed 
to influence Piezo2 mediated RA-MA currents (2-way ANOVA and post hoc Bonferroni 
test; Figure 17D).  
These results point to a microtubule independent mode of Piezo2 trafficking and also 
indicate that the role of Pcnt in MTOC (microtubule organizing complex) may not be the 
major factor in the Piezo2-Pcnt interaction.   
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3.4. Summary of part 1 
 Pericentrin (Pcnt) was identified as a low probability interactor of Piezo2 through a 
immunoprecipitation and mass-spectrometry approach  
 Pcnt co-immunoprecipitates with Piezo2-GST (in HEK293 cells) 
 Loss of Pcnt in DRG neurons potentiates RA-MA (Piezo2 mediated) currents, without 
affecting the IA-MA or SA-MA currents 
 Piezo2 membrane expression is increased in DRG neurons upon loss of Pcnt 
 Piezo2 RA-MA currents appear to be independent of microtubule dynamics 
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4. RESULTS: Part 2 
4.1. Verification of Piezo2-Mtmr2 interaction  
Mtmr2 is expressed in the somatosensory system 
The myotubularin related protein 2 (Mtmr2) was identified as a potential interactor of 
Piezo2 in the mass spectrometry based interactomics screen. It was one of the high 
affinity interactors with a p-value of 0.00030 and a 9.96-fold enrichment compared to 
control (Narayanan et al., 2016). Mtmr2 has previously been described in the context of 
somatosensation and identified in mouse DRG neurons and Schwann cells (Previtali et 
al., 2003). Its mutation is linked to CMT4B1, a peripheral neuropathy (Bolino et al., 2004; 
Bolis et al., 2005; Previtali et al., 2007).  
The first step in studying the Piezo2-Mtmr2 interaction was to characterize Mtmr2 
expression in relation to Piezo2 in DRG neurons. For this purpose DRG tissue from 
Piezo2GFP mouse was used (Woo et al., 2014). The tissue was immunostained for GFP 
and Mtmr2, as described in the methods section (2.1.3). I found that 24.53 ± 1.21% DRG 
neurons were positive for GFP immunolabel indicating the presence of Piezo2 and 20.37 
± 2.01% DRG neurons were Mtmr2 immunolabel positive. Of the Piezo2 positive cells, 
51.61 ± 3.71% cells were found to be Mtmr2 positive (Figure 18). This indicates that 
Piezo2 and Mtmr2 are expressed in overlapping populations of DRG neurons. Of note, 
an RNA-seq analysis of mouse DRG showed a ubiquitous expression of Mtmr2 among all 
classified neuronal subtypes (Usoskin et al., 2015).  
Figure 18: Mtmr2 expression in mouse DRG neurons 
Representative images (A) and quantification of Piezo2-GFP and Mtmr2 in DRG neurons (B). DRG neurons 
from Piezo2
GFP
 mice were immunolabelled for GFP (24.53 ± 1.21%) and Mtmr2 (20.37 ± 2.01%). A 51.61 ± 
3.71 % overlap between Mtmr2 and Piezo2-GFP staining was observed (n>2000 neurons from N=3 
independent mice). Arrows indicate co-labelled cells while arrowheads mark Mtmr2 positive cells. Scale bar 
= 50µm 
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Mtmr2 and Piezo2 localize in close proximity in HEK293 cells 
Based on the finding that a subset of DRG neurons expresses both Piezo2 and Mtmr2, I 
asked if within these cells the two proteins were expressed in close proximity. Limitations 
of the anti-Mtmr2 antibody in primary cultures of DRG neurons prompted the use of 
heterologous HEK293 cells to study the interaction of Piezo2 and Mtmr2 within the cell.  
Both proteins were co-expressed in HEK293 cells and proximity ligation assay (PLA) was 
carried out as described in the methods section (2.1.4).  
Figure 19A shows representative PLA images of Piezo2 and Mtmr2 in HEK293 cells. I 
found a significantly higher PLA signal (puncta/area of cell) upon co-expression of Piezo2 
with Mtmr2 compared to co-expression with mock plasmid (Mann Whitney test; Figure 
19B). This difference was also clearly reflected in the fraction of positive area (Mann 
Whitney test; Figure 19C).  
The results show that Piezo2 and Mtmr2 indeed localize in close proximity within HEK293 
cells. Of note, the exact subcellular localization of Piezo2-Mtmr2 interaction was not 
probed, because the subcellular localization could be confounded by the overexpression 
system.   
Figure 19: Piezo2 and Mtmr2 are expressed in close proximity in HEK293 cells 
Representative images (A) and quantification of proximity ligation assay (PLA) for Piezo2 and Mtmr2 
overexpressed in HEK293 cells (B). PLA signal is significantly higher when Piezo2 is co-expressed with 
Mtmr2 compared with mock plasmid. When quantified, the number of PLA puncta per cell area is 
significantly higher in Piezo2 + Mtmr2 compared to Piezo2 + mock (Piezo2 + mock: 0.05 ± 0.004 puncta/cell 
area; Piezo2 + Mtmr2: 0.11 ± 0.01 puncta/cell area; n=54-60 cells per condition;  p<0.0001; Mann Whitney 
test). Fraction of positive area (C) was also significantly increased upon Piezo2 co-expression with Mtmr2 
compared to mock (Piezo2 + mock: 0.04 ± 0.007; Piezo2 + Mtmr2: 0.34 ± 0.04; n=54-60 cells per condition; 
p<0.0001; Mann Whitney test). Dotted yellow lines have been used to demarcate cell boundaries. Scale 
bar= 10µm. *: p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are not significant unless otherwise 
stated. 
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4.2. Functional characterization of Piezo2-Mtmr2 interaction in HEK293 cells 
4.2.1. Mtmr2 co-expression suppresses Piezo2 RA-MA currents in HEK293 cells 
Piezo2 was overexpressed in HEK293 cells with either Mtmr2 or mock. MA currents were 
measured from these cells 48 hours after transfection.  
Interestingly, Mtmr2 co-expression lead to a highly significant reduction in the Piezo2 
mediated currents compared to mock (2-way ANOVA with Holm-Sidak’s multiple 
comparison test; Figure 20A and B). Concomitantly, the activation threshold of the RA-
MA currents was significantly increased upon overexpression with Mtmr2 (Mann Whitney 
test; Figure 20C). (Of note, the number of cells for which activation threshold was 
measured is different from the cells in the stimulus-current curves because of the very 
low current magnitudes of Mtmr2 overexpressing HEK293 cells. Cells that did not cross 
the current magnitude even at 6µm stimulus were not included in the activation threshold 
analysis). Interestingly, the Stim50 (stimulus required to elicit 50% of Imax) remained 
unchanged upon Mtmr2 co-expression (Mann Whitney test; Figure 20D). The inactivation 
time of the Piezo2 currents remained unchanged upon Mtmr2 co-expression with Piezo2 
(Mann Whitney test; Figure 20E). The data indicate the Mtmr2 co-expression with Piezo2 
suppresses Piezo2 mediated currents in HEK293 cells. Importantly, the defining property 
of RA-MA currents (fast inactivation τ) remains unchanged upon Mtmr2 co-expression. 
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Figure 20: Mtmr2 co-expression with Piezo2 in HEK293 cells suppresses RA-MA currents 
Representative traces of RA-MA currents in HEK293 cells overexpressing Piezo2 and mock or Piezo2  and  
Mtmr2 (A). Stimulus-current curves (B) show that Mtmr2 co-expression strongly suppresses Piezo2 
mediated RA-MA currents in HEK293 cells (Piezo2 + mock: n=11-17 cells; Piezo2 + Mtmr2: n=11-12 cells; 
2-way ANOVA reports a significant effect (P<0.001) Mtmr2 overexpression on RA-MA Piezo2 currents; 
Holm-Sidak’s multiple comparison test was used to compare both conditions at individual stimulus 
magnitudes, results represented on the graph with ‘*’.). Activation threshold (C) of RA-MA currents upon 
Mtmr2 overexpression is significantly higher than mock (Piezo2 + mock: 3.67 ± 0.29 µm, n=15 cells; Piezo2 
+ Mtmr2: 5.00 ± 0.52 µm, n=6 cells; p=0.045; Mann Whitney test). Stim50 of RA-MA currents (D) is 
unchanged upon Mtmr2 overexpression compared to mock (Piezo2 + mock: 4.34 ± 0.24 µm; Piezo2 + 
Mtmr2: 4.98 ± 0.09 µm; n=11 cells per condition; ns; Mann Whitney test). Inactivation time constant (τ) of 
RA-MA currents (E) was not significantly different between Piezo2 + mock and Piezo2 + Mtmr2 (Piezo2 + 
mock: 3.46 ± 0.42 ms, n= 17 cells; Piezo2 + Mtmr2: 3.48 ± 0.56 ms, n= 12 cells; ns; Mann Whitney test). *: 
p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are not significant unless otherwise stated.  
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4.2.2. Mtmr2 co-expression does not affect Piezo1 mediated MA currents or 
voltage dependent Kv1.1 currents in HEK293 cells 
As shown in Figure 20B, Mtmr2 strongly suppresses Piezo2 mediated currents in 
HEK293 cells. In order to assess the specificity of this effect I measured Piezo1 mediated 
MA currents and Kv1.1 mediated voltage gated currents upon Mtmr2 overexpression.  
Interestingly, no significant difference was found either in Piezo1 currents or Kv1.1 
currents upon co-expression of Mtmr2 compared to mock (2-way ANOVA with Holm-
Sidak’s multiple comparison test; Figure 21A and B respectively).  
These results indicate that Mtmr2 co-expression does not in general suppress ion 
channel expression or function, and attests to the specificity of the Piezo2-Mtmr2 
interaction. It also asserts that Mtmr2 overexpression does not affect the overall health of 
HEK293 cells.   
Figure 21: Mtmr2 co-expression does not affect Piezo1 or Kv1.1 currents in HEK293 cells 
Stimulus-current curves (A) for Piezo1 currents in HEK293 cells co-expressed with mock or Mtmr2. Mtmr2 
co-expression does not influence Piezo1 mediated currents (Piezo1 + mock: n=19-25 cells; Piezo1 + Mtmr2: 
n=12-20 cells; ns; 2-way ANOVA with Holm-Sidak’s multiple comparison test). Current-voltage curves (B) for 
Kv1.1 currents upon co-expression with mock or Mtmr2 plasmid. There is no significant effect of Mtmr2 co-
expression on the Kv1.1 currents (Kv1.1 + mock: n=23-24 cells; Kv1.1 + Mtmr2: n=25 cells; ns; 2-way 
ANOVA with Holm-Sidak’s multiple comparison test). *: p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; 
data are not significant unless otherwise stated.  
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4.3. Functional characterization of Piezo2-Mtmr2 interaction in DRG neurons 
4.3.1. Mtmr2 overexpression in DRG neurons decreases Piezo2 mediated 
current magnitude 
Based on the overexpression data in HEK293 cells it was important to study Piezo2-
Mtmr2 interaction in DRG neurons that express both proteins natively.  For this purpose I 
first overexpressed Mtmr2 in DRG neurons to recapitulate the phenotype observed in 
HEK293 cells.  
DRG neurons were cultured and transfected with the Mtmr2 construct and RA-MA 
currents were recorded 48 hours after transfection. Similar to HEK293 cells, Mtmr2 
overexpression suppressed the native RA-MA currents in these neurons (Figure 22A). 
The stimulus-current curves show a significant decrease in the RA-MA current magnitude 
upon overexpression of Mtmr2 compared to mock (2-way ANOVA with Holm-Sidak’s 
multiple comparison test; Figure 22B). 
Surprisingly though, neither the activation threshold nor the Stim50 of the RA-MA currents 
appears to have been significantly affected upon Mtmr2 overexpression (Mann Whitney 
test; Figure 22C and D). The difference in RA-MA regulation between HEK293 cells and 
DRG neurons could arise from either expression levels of the proteins, additional 
modulators that may be system exclusive or system specific differences in the Mtmr2-
Piezo2 interaction itself. To further characterize the Piezo2-Mtmr2 interaction in DRG 
neurons I used a siRNA based approach. 
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Figure 22: Mtmr2 overexpression in DRG neurons suppresses RA-MA currents 
Representative RA-MA traces for overexpression of Mtmr2 or mock in DRG neurons (A). Stimulus-current 
curves (B) of RA-MA currents in DRG neurons upon Mtmr2 overexpression. Mtmr2 overexpression 
significantly decreases RA-MA currents in DRG neurons (+ mock: n=22-28 neurons; + Mtmr2: n=27-30 
neurons; 2-way ANOVA reports a significant effect (P<0.01) of Mtmr2 overexpression on RA-MA Piezo2 
currents; Holm-Sidak’s multiple comparison test was used to compare both conditions at individual stimulus 
magnitudes, results are represented on the graph with ‘*’). Activation threshold of RA-MA currents (C) was 
unchanged upon overexpression of Mtmr2 (+ mock: 4.00 ± 0.31µm, n=23 neurons; + Mtmr2: 4.46 ± 0.26µm 
n=22 neurons; ns; Mann Whitney test). Stim50 of RA-MA currents (D) also remains unchanged upon Mtmr2 
overexpression (+ mock: 4.74 ± 0.14 µm, n=23 neurons; + Mtmr2: 4.86 ± 0.08 µm, n=28 neurons; ns; Mann 
Whitney test). *: p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are not significant unless otherwise 
stated.  
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4.3.2. Mtmr2 siRNA in DRG neurons effectively reduces Mtmr2 expression 
without affecting Piezo2 
Mtmr2 mRNA is decreased upon Mtmr2 knockdown in DRG neurons 
Primary cultures of DRG neurons were transfected with Mtmr2 siRNA as described in the 
methods section (2.2.1). All analysis was done 72 hours after transfection. In order to 
assess the efficiency of the siRNA, quantitative PCR was performed as described in the 
methods section (2.2.2). Amount of Mtmr2 mRNA was quantified with reference to 
housekeeping genes GAPDH and actin. Mtmr2 siRNA significantly reduced the Mtmr2 
mRNA compared to CTRL relative to both housekeeping genes (One sample t-test; 
Figure 23A).  
Further, Piezo2 mRNA was also analyzed upon Mtmr2 knockdown and no significant 
difference was observed compared to CTRL (One sample t-test; Figure 23B). The above 
data show that the Mtmr2 siRNA is highly effective in reducing Mtmr2 mRNA in DRG 
neuron cultures, while Piezo2 mRNA remains unaffected. 
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Piezo2 membrane expression is unchanged upon Mtmr2 knockdown 
To study the effect of Mtmr2 knockdown on Piezo2 in DRG neurons, membrane 
expression of Piezo2 was measured using immunolabelling. DRG neurons from 
Piezo2GFP mice (Woo et al., 2014) were transfected with Mtmr2 siRNA and 
immunolabelled against GFP, 72 hours post transfection.  Analysis of membrane intensity 
was done as described in the methods section (2.2.4). I found no significant difference in 
the membrane intensity of Piezo2-GFP staining upon transfection with Mtmr2 siRNA 
compared to CTRL (Mann Whitney test; Figure 23C and D). In conclusion, Mtmr2 
knockdown changes neither Piezo2 mRNA levels nor the membrane expression of 
Piezo2.    
4.3.3. Mtmr2 knockdown potentiates Piezo2 mediated MA currents 
As described earlier Mtmr2 expression was suppressed in DRG neurons using siRNA. 
RA-MA currents were measured from the cells 72 hours after transfection. Remarkably, 
the RA-MA current magnitude was increased upon knockdown of Mtmr2 compared to 
CTRL (2-way ANOVA with Holm-Sidak’s multiple comparison test; Figure 24B). Further 
analysis revealed that the activation threshold of the RA-MA currents was significantly 
decreased upon Mtmr2 knockdown (Mann Whitney test; Figure 24C). I also analyzed the 
Stim50 of the RA-MA currents and found no significant difference between CTRL and 
Mtmr2 siRNA conditions (Mann Whitney test; Figure 24D). It is important to note here 
that the MA current data cannot be compared between the different experiments namely 
overexpression of Mtmr2 and knockdown of Mtmr2, because of the differences in the 
transfection conditions and recording days in vitro (DIV). Hence each set of data was 
performed with its own controls. 
Figure 23: Knockdown of Mtmr2 in DRG neurons 
Mtmr2 siRNA mediated knockdown in DRG neurons (A) significantly decreases Mtmr2 (Mtmr2 mRNA upon 
Mtmr2 siRNA, actin as reference: 0.42 ± 0.05; p<0.0001; One sample t-test; N=8 DRG cultures). No change 
in Piezo2 mRNA (B) was observed (Piezo2 mRNA upon Mtmr2 siRNA, actin as reference: 1.17 ± 0.18; ns; 
One sample t-test; N=8 DRG cultures). Representative images (C) and quantification (D) of Piezo2 
membrane intensity upon Mtmr2 knockdown in DRG neurons. Membrane immunofluorescence of Piezo2-
GFP remained unchanged upon Mtmr2 knockdown (CTRL: 1470 ± 246.7 AU; Mtmr2 siRNA: 1424 ± 237.5 
AU; ns; Mann Whitney test; n=22 neurons per condition). Scale bar= 5µm. *: p<0.05; **: p<0.01; ***: 
p<0.0001; ****: p<0.00001; data are not significant unless otherwise stated. 
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The results show that Mtmr2 is capable of bi-directional regulation of Piezo2 RA-MA 
currents in DRG neurons  
 
Figure 24: Mtmr2 knockdown in DRG neurons potentiates RA-MA currents 
Representative traces of RA-MA currents in CTRL and Mtmr2 siRNA treated DRG neurons (A). Stimulus-
current curves (B) show that Mtmr2 knockdown leads to significant increase in the Piezo2 mediated RA-MA 
currents (CTRL: n=59-68 neurons; Mtmr2 siRNA: n=63-78 neurons; 2-way ANOVA reports a significant 
effect (P<0.001) of the loss of Mtmr2 on RA-MA Piezo2 currents; Holm-Sidak’s multiple comparison test was 
used to compare both conditions at individual stimulus magnitudes, results are represented on the graph 
with ‘*’). Activation threshold (C) of Mtmr2 knockdown neurons is significantly lower than CTRL (CTRL: 3.95 
± 0.17 µm, n=65 neurons; Mtmr2 siRNA: 3.44 ± 0.17, n=75 neurons; p=0.033; Mann Whitney test). Stim50 of 
RA-MA currents (D) remains unchanged upon Pcnt knockdown (CTRL: 4.61 ± 0.06 µm, n= 58 neurons; 
Mtmr2 siRNA: 4.62 ± 0.06, n= 63 neurons; ns; Mann Whitney test). Of note, current traces and magnitude 
cannot be compared to data from other experiments because of differences in days in vitro (DIV) of 
recording and different transfection treatments. Hence all independent experiments were performed with 
respective controls. *: p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are not significant unless 
otherwise stated. 
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4.3.4. Mtmr2 knockdown does not affect other MA currents but affects 
population distribution of MA currents 
As mentioned in the section 1.2.2, DRG neurons display three types of MA currents 
based in their inactivation time constant (τ).  
Two of these MA currents, intermediate and slowly adapting currents (IA and SA) are not 
directly Piezo2 mediated (Coste et al., 2010; Dubin et al., 2012; Ranade et al., 2014) and 
can therefore be used to study the specificity of Piezo2-Mtmr2 interaction.  
As shown in Figure 25A and B neither the IA-MA nor the SA-MA currents were 
significantly changed upon Mtmr2 knockdown (2-way ANOVA with Holm-Sidak’s multiple 
comparison test; Figure 25A and B respectively).  
This data provides additional proof for the specificity of the Piezo2-Mtmr2 interaction (in 
HEK293 cells it was seen that Mtmr2 does not interact with Piezo1 and Kv1.1; Figure 
21).  
Besides single cell properties, I also looked at the population of the MA currents in the 
DRG cultures treated with CTRL or Mtmr2 siRNA. Surprisingly, I found that there was a 
significant redistribution of the MA currents upon Mtmr2 knockdown. There was an 
increase in the proportion of RA-MA exhibiting cells with a concomitant decrease in the 
IA-MA exhibiting population (Chi-Square test; Figure 25C). This was a surprising 
observation considering there is no indication for the involvement of Piezo2 in the IA-MA. 
Surprisingly, the number of Piezo2 positive DRG neurons remains unchanged upon 
Mtmr2 knockdown (% of Piezo2-GFP positive cells in CTRL: 29.59 ± 4.97%; Mtmr2 
siRNA: 33.59 ± 2.45%; ns; Mann Whitney test; N=3 DRG cultures; data not shown) and 
no change in the overall Piezo2 mRNA was found (Figure 23B). Considering that the 
increased population of RA-MA currents is not contributed by increased number of 
Piezo2 positive cells, it is possible that Mtmr2 interacts with other ion channels (including 
the one generating IA-MA currents) and modulates their properties. Further 
understanding of this data awaits the characterization of the ion channels involved in 
generating IA-MA currents (Viatchenko-Karpinski and Gu, 2016).  
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Figure 25: Mtmr2 knockdown does not modulate IA-MA and SA-MA currents 
Stimulus-current curves of IA (A) and SA (B)-MA currents under CTRL or Mtmr2 siRNA conditions show no 
significant differences (IA-MA: CTRL: n=24 neurons; Mtmr2: n=9-10 neurons; ns. SA-MA: n=16-17 neurons 
per condition; ns; 2-way ANOVA with Holm-Sidak’s multiple comparison test). Stacked histogram showing 
distribution of RA-MA, IA-MA, SA-MA and NR (non-responder) neurons in DRG cultures (C) treated with 
CTRL or Mtmr2 siRNA. RA-MA currents are significantly increased while the IA-MA currents are 
concomitantly decreased upon Mtmr2 knockdown (RA:IA:SA:NR; CTRL: 46:16:9:29; Mtmr2 siRNA: 
58:7:12:23; p=0.0439; Chi-Square test; >130 neurons were analyzed per condition). Chi-square test for RA-
MA/total: p=0.048 and IA-MA/total: p=0.023. Numbers have been rounded off to reflect whole numbers. *: 
p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are not significant unless otherwise stated. 
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4.4. Probing mechanism of Piezo2-Mtmr2 interaction 
In order to elucidate the mechanism of the Piezo2-Mtmr2 interaction, I focused on the 
cellular role of Mtmr2. As shown in Figure 8B, Mtmr2 is a phosphatase that catalysis the 
removal of the 3-phosphate group from PI(3)P and PI(3,5)P2 (Berger et al., 2002). PIPs 
have been known to regulate ion channels (Gamper and Shapiro, 2007) and recent 
evidence also suggests that Piezo2 can be modulated by phosphatidylinositols (Borbiro 
et al., 2015; Jia et al., 2016).  
In light of this information, certain fundamental questions were asked. A) Is the catalytic 
role of Mtmr2 relevant to Mtmr2-Piezo2 interaction? B) Are the PIPs involved in the 
Mtmr2-Piezo2 interaction? and C) Can PIPs directly modulate Piezo2?  
4.4.1. Catalytically inactive Mtmr2 C417S does not influence RA-MA currents 
To know if the catalytic activity of Mtmr2 has a role to play in the Piezo2-Mtmr2 
interaction, I generated an Mtmr2 mutant construct containing the C417S mutation 
(cysteine at position 417 modified to serine). This mutation renders the phosphatase 
catalytically inactive (Berger et al., 2002). If the catalysis of PI(3,5)P2 and PI(3)P would be 
essential to the interaction of Piezo2-Mtmr2, the catalytically inactive mutant would fail to 
recapitulate the Piezo2 RA-MA suppression caused by the overexpression with wild type 
Mtmr2, in HEK293 cells (Figure 20B). Extraordinarily, this was indeed found to be the 
case. The Mtmr2C417S construct fails to suppress Piezo2 mediated currents in HEK293 
cells. In fact, the overexpression with Mtmr2C417S caused a mild but significant increase 
in the RA-MA currents. Stimulus-current curves (2-way ANOVA with Holm-Sidak’s 
multiple comparison test; Figure 26A) show the small increase of RA-MA currents upon 
co-expression with Mtmr2C417S. Activation threshold (Mann Whitney test; Figure 26B) 
was unchanged upon overexpression of Piezo2 with the Mtmr2C417S construct. This 
result strongly suggests that Mtmr2 catalytic activity is essential for it to modulate Piezo2 
currents and hints to the possibility of PI(3,5)P2 and PI(3)P being involved in the 
interaction. In order to check if the proximity of Piezo2 and Mtmr2 is affected by the 
C417S mutation, I performed proximity ligation assay. Interestingly, Mtmr2C417S despite 
its loss of enzymatic activity still localizes in close proximity to Piezo2 in HEK293 cells. 
Figure 26C shows representative PLA images of Piezo2 co-expressed with Mtmr2, 
Mtmr2C417S or mock in HEK293 cells. A significantly higher PLA signal was observed 
(puncta/area of cell) upon co-expression of Piezo2 with Mtmr2C417 compared to co-
expression with Mock plasmid.   
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There was no difference between the PLA signal upon co-expression of Piezo2 with 
Mtmr2 or Mtmr2C417S (Kruskal Wallis test with Dunn’s Multiple Comparison Test; 
Figure 26D). Similar results were obtained when comparing fraction of positive area 
(Kruskal Wallis test with Dunn’s Multiple Comparison Test; Figure 26E). This data 
indicates that enzymatically inactive Mtmr2 (Mtmr2C417S) remains capable of 
associating with Piezo2 but loses the ability to modulate Piezo2 RA-MA currents. 
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4.4.2. Apilimod (and to a lesser extent Wortmannin) application can ‘reverse’ 
Mtmr2 knockdown phenotype  
Apilimod decreases RA-MA currents which were increased upon Mtmr2 knockdown 
neurons 
To answer if the PIPs are involved in the Piezo2-Mtmr2 interaction I used 
pharmacological manipulation of the PIP synthesis and turnover pathway. As shown in 
Figure 27A, Apilimod is a specific inhibitor of PIKfyve, the enzyme that generates 
PI(3,5)P2 (Cai et al., 2013; Messenger et al., 2015). From the figure it can also be seen 
that decreasing Mtmr2 would cause an increase in the levels of PI(3,5)P2. Therefore if 
PI(3,5)P2 would be a relevant component of the Piezo2-Mtmr2 interaction, Apilimod 
application would be expected to ‘rescue/reverse’ the increased RA-MA currents caused 
by knockdown of Mtmr2. With this in mind, Mtmr2 knockdown DRG neurons were treated 
with Apilimod as described in the methods section (2.2.6). Figure 27B shows the 
stimulus-current curves for RA-MA currents in DRG neurons. Apilimod application 
significantly reduces the magnitude of RA-MA currents in Mtmr2 knockdown neurons (2-
way ANOVA with Holm-Sidak’s multiple comparison test; Figure 27B). Concomitantly, 
Figure 26: Mtmr2C417S does not affect Piezo2 currents in HEK293 cells 
Stimulus-current curves for Piezo2 RA-MA currents in HEK293 cells upon co-expression with mock or 
Mtmr2C417S construct (A). Mtmr2C417S co-expression causes a mild but significant potentiation of Piezo2 
RA-MA currents (Piezo2+mock: n=24-33 cells; Piezo2+Mtmr2C417S: n=14-18 cells; P<0.05; 2-way ANOVA. 
Holm-Sidak’s multiple comparison test shows no significant differences at individual stimulus magnitudes). 
Activation properties (B) of RA-MA currents remain unchanged upon overexpression of Piezo2 with 
Mtmr2C417S compared to overexpression with mock (Piezo2+mock: 4.26 ± 0.24 µm, n=27 cells; 
Piezo2+Mtmr2C417S: 3.81 ± 0.44 µm, n=16 cells; ns; Mann Whitney test). Representative images of 
proximity ligation assay for co-expression of Piezo2 with mock, Mtmr2 and Mtmr2C417S (C). PLA signal is 
significantly higher when Piezo2 is co-expressed with Mtmr2 or with Mtmr2C417S compared with mock 
plasmid. Both puncta/area of cell (D) and fraction of positive area (E) show that Mtmr2 and Mtmr2 C417S 
localize in close proximity to Piezo2 in HEK293 cells.  
(Puncta/cell: Piezo2 + mock: 0.05 ± 0.003 puncta/cell, n=75 cells; Piezo2 + Mtmr2: 0.18 ± 0.01 puncta/cell, 
n=70 cells; Piezo2 + Mtmr2C417S: 0.17 ± 0.09 puncta/cell, n=70 cells; Piezo2 + mock versus Piezo2 + 
Mtmr2: p<0.0001; Piezo2 + mock  versus Piezo2 + Mtmr2C417S: p<0.0001 ; Piezo2 + Mtmr2 versus Piezo2 
+ Mtmr2C417S: ns; Kruskal Wallis test with Dunn’s Multiple Comparison Test).  
(Fraction of positive area: Piezo2 + mock: 0.01 ± 0.003, n=75 cells; Piezo2 + Mtmr2: 0.25 ± 0.03, n=70 cells; 
Piezo2 + Mtmr2C417S: 0.25 ± 0.03, n=70 cells; Piezo2 + mock versus Piezo2 + Mtmr2: p<0.0001; Piezo2 + 
mock versus Piezo2 + Mtmr2C417S: p<0.0001 ; Piezo2 + Mtmr2 versus Piezo2 + Mtmr2C417S: ns; Kruskal 
Wallis test with Dunn’s Multiple Comparison Test). Yellow dotted lines have been used to demarcate cell 
boundaries. Scale bar = 20µm. *: p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are not significant 
unless otherwise stated. 
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the activation threshold of the RA-MA currents was increased significantly upon Apilimod 
treatment (Mann Whitney test; Figure 27D). This result points to a role for PI(3,5)P2 in the 
Piezo2-Mtmr2 interaction. 
Interestingly, Apilimod application on wild type DRG neurons did not have an impact on 
the RA-MA current magnitude (2-way ANOVA with Holm-Sidak’s multiple comparison 
test; Figure 27E) or on activation threshold (Mann Whitney test; Figure 27F). This result 
may be explained by the low cellular expression of PI(3,5)P2 under physiological 
conditions (Jin et al., 2016; McCartney et al., 2014a). Therefore an Apilimod mediated 
decrease of the already low PI(3,5)P2 in wild type DRG neurons may not produce a 
cellular effect.  
Wortmannin shows mild effect on RA-MA currents in Mtmr2 knockdown neurons 
In cellular systems, Mtmr2 has two substrates PI(3,5)P2  and PI(3)P. In the above section 
I looked at the role of the former because it was shown to be the preferential substrate 
(Berger et al., 2002). Following those results, I asked if PI(3)P may also be involved in 
the Piezo2-Mtmr2 interaction. Towards this goal, Wortmannin an inhibitor of the class III 
PI 3-kinase was used (Messenger et al., 2015). Mtmr2 knockdown DRG neuron cultures 
were treated with Wortmannin and RA-MA currents recorded. This treatment showed a 
mild but significant effect on RA-MA currents, as seen from the 2-way ANOVA. Though at 
the individual stimulus magnitudes, the two conditions were not significantly different. (2-
way ANOVA with Holm-Sidak’s multiple comparison test; Figure 27C).  
The activation threshold of cells treated with Wortmannin did not significantly differ from 
the cells treated with DMSO (Mann Whitney test; Figure 27D). These results suggest 
that PI(3)P may play a small role in the Piezo2-Mtmr2 interaction. The relevance of this 
role and how it co-relates with PI(3,5)P2 in Piezo2 regulation remains to be assessed.   
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Figure 27: Mtmr2 knockdown can be rescued by Apilimod application 
Schematic illustration of the PI(3)P and PI(3,5)P2 synthesis and turnover pathway, indicating the action of 
Apilimod and Wortmannin, which are blockers of PIKfyve and class III PI3-Kinase respectively (A). Stimulus-
current curves of Piezo2 RA-MA currents in Mtmr2 knockdown neurons upon application of Apilimod (B). 
Apilimod treatment significantly reduces RA-MA currents (Mtmr2 siRNA+DMSO: n=21-27 neurons; Mtmr2 
siRNA+Apilimod: n=24-30 neurons; 2-way ANOVA reports that Apilimod treatment has a significant effect 
(P<0.001) on RA-MA Piezo2 currents; Holm-Sidak’s multiple comparison test was used to compare both 
conditions at individual stimulus magnitudes, results are represented on the graph with ‘*’). Stimulus-current 
curves of RA-MA current in Mtmr2 knockdown DRG neurons upon application of Wortmannin (C). 
Wortmannin application has a significant effect on RA-MA currents (Mtmr2 siRNA+DMSO: n=21-27 neurons; 
Mtmr2 siRNA+Wortmannin: n=27-29 neurons; 2-way ANOVA (p<0.01); Holm-Sidak’s multiple comparison 
test showed no significant difference between individual current densities at different stimulus intensities). 
Activation threshold of RA-MA currents (D) is increased upon Apilimod treatment (Mtmr2 siRNA+DMSO: 
3.52 ± 0.24 µm, n=26 neurons; Mtmr2 siRNA+Apilimod: 4.36 ± 0.28 µm, n=27 neurons; p=0.0179; Mann 
Whitney test), while Wortmannin treatment did not change the activation threshold of RA-MA currents 
compared to DMSO application (Mtmr2 siRNA+DMSO: 3.52 ± 0.24 µm; Mtmr2 siRNA+Wortmannin: 4.07 ± 
0.24 µm; ns; n=27 neurons per condition; Mann Whitney test). Stimulus-current curves of native RA-MA 
currents upon application of Apilimod (E). Apilimod application in wild type DRG neurons does not affect the 
Piezo2 RA-MA currents (+DMSO: n=14-16 neurons; +Apilimod: n=8-13 neurons; 2-way ANOVA with Holm-
Sidak’s multiple comparison test). Activation properties of RA-MA currents (F) were also unchanged (+ 
DMSO: 3.88 ± 0.44 µm, n=16 neurons; + Apilimod: 3.31 ± 0.52 µm, n=13 neurons; ns; Mann Whitney test). 
*: p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are not significant unless otherwise stated. 
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4.4.3. Increasing levels of PI(3)P and PI(3,5)P2 in DRG neurons shows no effect 
From the scheme in Figure 27A, it can be inferred that loss of Mtmr2 increases 
PI(3,5)P2. I attempted to recapitulate this effect using synthetic PIPs to artificially increase 
PIPs in DRG neurons. As described in the methods section (2.2.6), diC8 PI(3,5)P2 or 
diC8 PI(3)P (Echelon) was included in the intracellular recording solution during the 
measurement of MA currents (Dong et al., 2010). No significant effects were observed on 
RA-MA currents upon application of diC8 PI(3,5)P2 or diC8 PI(3)P to the DRG neurons (2-
way ANOVA with Holm-Sidak’s multiple comparison test; Figure 28A). No significant 
differences were observed in the activation thresholds of the RA-MA currents either 
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(Kruskal-Wallis test with Dunn’s Multiple Comparison Test; Figure 28B). Of note, Dong 
and colleagues, used a similar approach to show the regulation of TRPML1 channels by 
PI(3,5)P2 and PI(3)P (Dong et al., 2010).  
There could be several factors for the phospholipid addition not affecting RA-MA 
currents. The localization of the externally added PIPs may not correspond to the native 
cellular localization thus varying the action on targets. Additionally, the phosphatases 
either in the recording solution or inside the cell may break down the externally 
introduced PIPs before they can find their cellular target. Due to technical factors that 
may confound this data, a biochemical approach was used study Piezo2 and PI(3,5)P2 
interaction and the role Mtmr2 may play in it. 
 
 
 
 
 
 
 
 
Figure 28: Synthetic PIP addition to DRG neurons does not affect RA-MA currents 
Stimulus-current curves for RA-MA currents in DRG neurons upon addition of diC8 PIPs in intracellular 
solution (A) shows no difference between the applications of different concentrations of PIPs compared to 
control (CTRL: n=20-23 neurons; +1µM PI(3)P: n=16 neurons; +100nM PI(3,5)P2: n=11-12 neurons; 1µM 
PI(3,5)P2:n=13-14 neurons; ns; 2-way ANOVA with Holm-Sidak’s multiple comparison test). Activation 
threshold upon application of diC8 PIPs intracellularly to DRG neurons (B) shows no significant differences 
compared to control (CTRL: 4.30 ± 0.27 µm, n=23 neurons; +1µM PI(3)P: 3.67 ± 0.40 µm, n=15 neurons; 
+100nM PI(3,5)P2: 3.17 ± 0.51 µm, n=12 neurons; 1µM PI(3,5)P2: 3.50 ± 0.48 µm, n=14 neurons; ns; 
Kruskal-Wallis test with Dunn’s Multiple Comparison Test). *: p<0.05; **: p<0.01; ***: p<0.0001; ****: 
p<0.00001; data are not significant unless otherwise stated.  
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4.4.4. Piezo2 and Mtmr2 contain putative PI(3,5)P2 binding motifs 
PIPs are known to bind to proteins through defined domains such as the FYVE domain, 
WD40 domain, PHD domain etc. or electrostatically to poly-basic regions with 
unstructured basic amino acid residues (Lysine or Arginine) (Dong et al., 2010; 
McCartney et al., 2014a). In order to glean if similar regions exist in the Piezo2 and 
Mtmr2 structures, I compared the structure of these proteins with a known PI(3,5)P2 
binding motif from the TRP channel, TRPML1. Dong and colleagues reported that 
PI(3,5)P2 binds to the N-terminus region of TRML1 (Dong et al., 2010). Sequence 
comparison was done using NCBI protein blast (Protein [Internet]. Bethesda (MD): 
National Library of Medicine (US), National Center for Biotechnology Information). 
Illustration in Figure 29 shows the results of this comparison. I found regions in both 
Piezo2 and Mtmr2 with considerable sequence similarity to the proposed PI(3,5)P2 
binding sequence of TRPML1. Worth noting is the interesting feature of these regions. 
The Piezo2 and Mtmr2 regions show similarity to mutually independent regions of the 
TRPML1 sequence and in effect combine to complete the PI(3,5)P2 binding sequence of 
TRPML1.  
In order to test, if the sequences identified in Piezo2 and Mtmr2 indeed bind to PI(3,5)P2, 
the peptide-lipid binding assay was used as described in the methods section (2.2.5). 
Peptides of Piezo2 and Mtmr2 encompassing the regions mentioned in Figure 29 were 
purchased from GenScript (peptide sequences are provided in the supplementary table 
5). Interestingly, the results show that both Piezo2 and Mtmr2 peptides bind to PI(3,5)P2 
(Figure 30A and B). Besides PI(3,5)P2, Mtmr2 also binds PI(3P), PI(4)P, PI(5)P, and 
PI(4,5)P2. Earlier studies have explored the binding of Mtmr2 to PIPs. It has been shown 
that the full length Mtmr2C417S and Mtmr2E276X (which contains only the PH-GRAM 
domain of the protein) binds to PI(3,5)P2, PI(3,4,5)P3, PI(4)P,  and PI(5)P (Berger et al., 
2003). Another study also showed that Mtmr2 can bind to PI(3)P and PI(3,5)P2 (Begley et 
al., 2006).  
In the case of Piezo2 peptide besides PI(3,5)P2, it also bound to PI(4,5)P2. This is an 
interesting observation because in 2015 Borbiro and colleagues showed that TRPV1 
modulates Piezo2 currents through PI(4,5)P2 depletion, though the PI(4,5)P2 binding 
region of Piezo2 was not identified in the study  (Borbiro et al., 2015).  
In order to test the relevance of the basic amino acids to the Piezo2-PI(3,5)P2 binding, I 
generated a 3Q mutant of the Piezo2 peptide (Figure 29; Piezo2 3Q mutant; 
QQILQYFWMS). The basic amino acid residues in the Piezo2 peptide were changed to 
neutral Glutamine (Q). Remarkably, the Piezo2 3Q mutant does not bind to PI(3,5)P2 
(Figure 30C). This observation indicated, that the basic residues in the Piezo2 peptide 
sequence are essential for the binding to PI(3,5)P2. Considering the interesting bi-partite 
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arrangement of the Piezo2 and Mtmr2 peptide sequences as shown in Figure 29, I asked 
if the Piezo2 and Mtmr2 peptide bind to each other. For this the peptide-peptide overlay 
assay was used as described in the methods section (2.2.5). As shown in Figure 30D, 
the Mtmr2 peptide binds to the Piezo2 peptide, but not to the Piezo2 3Q mutant 
described earlier. Another Piezo2 peptide (Piezo2X) was generated encompassing a 
region similar to the Piezo2 peptide. It contained similar basic amino acid residues as the 
Piezo peptide, only arranged differently (LWMIRNRRKYAMISSP). The fact that the 
Mtmr2 peptide fails to bind to Piezo2 X peptide indicates that the Mtmr2-Piezo2 
interaction not only requires the presence of basic amino acids but also depends on the 
exact amino acid sequence. Additional controls including TRPA1 and TRPV1 peptides 
were all negative (data not shown). This data points to a possible tripartite interaction 
between Piezo2-Mtmr2 and PI(3,5)P2. The exact structural make up of this interaction 
remains to be studied. It is important to note here that the peptide regions defined here 
may not be the only PI(3,5)P2 binding regions in Piezo2 and Mtmr2. In fact, a study 
describing the Mtmr2- PI(3,5)P2 binding pocket identified other regions in the protein that 
can bind to PI(3,5)P2 (Begley et al., 2006). Of note, in order to study the relevance of the 
region shown above in Piezo2 function, I designed a Piezo2 3Q mutant construct (the 
basic amino acids in the Piezo2 region described in Figure 29 were changed to 
Glutamine (Q)). The mutant construct failed to express as a functional channel in 
HEK293 cells and hence RA-MA currents could not be measured. 
 
 
 
 
 
Figure 29: PIP2 binding sequences in Piezo2, Mtmr2 and TRPML1 
Schematic illustration of the protein sequences which show the PI(3,5)P2 binding regions of the TRPML1, 
Mtmr2 and Piezo2. TRPML1 binds to PI(3,5)P2 through its N-terminal region as described in Dong et al. 
(2010). Mtmr2 and Piezo2 sequences that have significant sequence similarities were identified using NCBI 
protein Blast (Protein [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for 
Biotechnology Information). Additionally, Piezo2 3Q peptide is also shown, in which the basic amino acids 
have been mutated to neutral (Q, Glutamine) residues.  
 
78 |  R E S U L T S :  P A R T  2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: Piezo2 and Mtmr2 bind to PI(3,5)P2 
Representative immunoblot of Mtmr2 peptide on PIP strip (A) shows that Mtmr2 binds to PI(3,5)P2 (arrow). 
Mtmr2 also binds to PI(4,5)P2, PI(3)P, PI(4)P and PI(5)P. Representative immunoblot of PIP strip bound to 
Piezo2 peptide (B) shows that Piezo2 binds to PI(3,5)P2 (arrow) and PI(4,5)P2. Representative immunoblot 
of PIP strip bound to Piezo2 3Q peptide (C). The 3Q peptide contains the basic amino acids changed to 
neutral glutamine (Q). Piezo2 3Q does not bind to PI(3,5)P2. Representative dot blot (D) shows Piezo2 and 
Mtmr2 peptides bind to each other. As control, Mtmr2 does not bind to the Piezo2 3Q peptide or to the 
Piezo2 X peptide. (Piezo2 X peptide was generated encompassing a region similar to the Piezo2 peptide 
containing basic amino acids; for sequence information please refer to Supplementary Table 5). Dotted lines 
indicate the region of peptide application. 
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4.4.5. Physiological manipulation of PIP levels in DRG neurons 
So far the experiments point to a role for PI(3,5)P2, in the Piezo2-Mtmr2 interaction and 
that the three may form a tripartite interaction complex. As described earlier, PI(3,5)P2 is 
a low abundance phosphatidylinositol whose levels change in response to cellular stress. 
Osmotic shock in eukaryotic cells was shown to transiently increase the cellular levels of 
PI(3,5)P2. The increase was shown to last for 10 minutes and then drop to baseline 
immediately (McCartney et al., 2014a). Based on this evidence, osmotic stress was used 
in DRG neurons to further analyze the interplay of PIP2 levels and Piezo2 function. It has 
already been shown that Piezo2 RA-MA currents in DRG neurons are modulated by 
osmotic stress (Jia et al., 2016), without affecting single channel properties. The study 
showed that osmotic swelling causes potentiation of RA-MA currents in rat DRG neurons 
due to changes in the static plasma membrane tension.  
Extracellular hypotonic stress potentiates Piezo2 mediated current magnitude in DRG 
neurons  
I tested this osmotic stress paradigm in DRG cultures from mice and found that 
extracellularly applied hypotonic solution indeed caused potentiation of the Piezo2 RA-
MA currents. The RA-MA current magnitude in hypotonic extracellular solution treated 
cells was significantly higher than control (2-way ANOVA with Holm-Sidak’s multiple 
comparison test; Figure 31A). Strikingly, Apilimod application partially attenuated the 
potentiation of RA-MA currents (2-way ANOVA with Holm-Sidak’s multiple comparison 
test; Figure 31B). Furthermore, the activation threshold of the RA-MA currents was 
significantly decreased upon treatment with hypotonic extracellular solution (Green bar; 
1-way ANOVA with Uncorrected Fisher’s LSD; Figure 31C). This decrease of threshold 
could be rescued by the application of Apilimod (Red bar; 1-way ANOVA with 
Uncorrected Fisher’s LSD; Figure 31C). In the above mentioned study Jia and 
colleagues also reported that prolonged exposure of DRG neurons to hypotonic stress 
causes a slowing down of the inactivation (Jia et al., 2016). In order to ensure that the 
MA currents measured here were of the RA-MA category, I tested the inactivation time 
constant of the currents. The inactivation time constant (τ) was unchanged upon 
application of hypotonic stress compared to isotonic extracellular solution (Isotonic extra 
solution: 2.93 ± 0.41 ms, n=22 neurons; Hypotonic extra solution: 2.88 ± 0.24 ms, n=24 
neurons; ns; Mann Whitney test).  
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Apilimod reverses the hypersensitivity caused by hypotonic saline injection in mouse paw 
Remarkably, the effect of hypotonic stress in vitro and its rescue by Apilimod application 
could be recapitulated in behavior experiments in mice. Responses to innocuous 
mechanical stimuli are a commonly used measure to study Piezo2 function in vivo 
(Eijkelkamp et al., 2013; Poole et al., 2014; Ranade et al., 2014). Mouse paw is 
stimulated using a mechanical filament and the force which elicits a withdrawal response 
is measured. Lower forces required to elicit withdrawal response indicates 
hypersensitivity of the paw. Unilateral injection of hypotonic saline (0.5X dPBS) to the 
mouse plantar hind paw surface leads to a hypersensitivity to innocuous mechanical 
stimuli (please refer to methods section for details). Quantification of mechanical 
threshold (force, g) illustrates the tactile allodynia induced upon injection of hypotonic 
saline when comparing ipsilateral (injected paw; green triangle) versus contralateral 
(uninjected paw; green circle) (2-way ANOVA for repeated measures followed by Holm-
Sidak’s multiple comparison test; Figure 31D). Additionally, in line with the data shown in 
Figure 31B and C, Apilimod co-injection with hypotonic saline to the hind paw plantar 
surface, significantly increases the hind paw mechanical threshold indicating an 
alleviation of the tactile allodynia (2-way ANOVA for repeated measures followed by 
Holm-Sidak’s multiple comparison test; Figure 31D). It is relevant to note here that 
Apilimod alone injected in mouse paw does not influence mechanical sensitivity (data not 
shown), which is in line with the in vitro data shown in Figure 27E and F. Based on these 
data it can be said that PI(3,5)P2 has a role to play in modulating mechanical sensitivity 
both in vitro and in vivo. The extent to which this regulation is mediated by Piezo2 
remains to be tested. Other proteins like TRPV4 through its role as an osmo-sensor may 
be affected by the application of hypotonic stress (Jia et al., 2016; Lechner et al., 2011; 
Liu et al., 2007; Quallo et al., 2015). Interestingly in vitro, Jia and colleagues showed that 
the Piezo2 potentiation in DRG neurons upon exposure to osmotic stress is independent 
of TRPV4 function (Jia et al., 2016).           
R E S U L T S :  P A R T  2  | 81 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: Apilimod rescues potentiation of RA-MA currents and mechanical allodynia, caused by 
osmotic stress  
Stimulus-current curves of RA-MA currents in DRG neurons upon exposure to hypotonic extracellular stress 
(A) shows a significant potentiation of RA-MA currents compared to control (Isotonic extracellular solution: 
n=23-29 neurons; Hypotonic extracellular solution: n=26-29 neurons; 2-way ANOVA reports that hypotonic 
extracellular stress has a significant effect (P<0.0001) on RA-MA Piezo2 currents; Holm-Sidak’s multiple 
comparison test was used to compare both conditions at individual stimulus magnitudes, results are 
represented on the graph with ‘*’). (B) Apilimod application alleviates the RA-MA potentiation caused by the 
hypotonic stress (Isotonic extracellular solution: n=23-29 neurons; Hypotonic extracellular solution: n=26-29 
neurons (same datasets as above); Hypotonic extracellular solution + Apilimod: n=14-15 neurons). 2-way 
ANOVA suggests that Apilimod can alleviate the Piezo2 RA-MA potentiation (P<0.05). Holm-Sidak’s multiple 
comparison test was used to compare both conditions at individual stimulus magnitudes, results are 
represented on the graph with ‘*’. Activation threshold of RA-MA currents under hypotonic extracellular 
stress (C) shows a pattern consistent with the stimulus-current curves (Extracellular isotonic solution: 3.74 ± 
0.29 µm, n=23 neurons; Extracellular hypotonic solution: 2.90 ± 0.26 µm, n=29 neurons; Extracellular 
hypotonic solution + Apilimod: 3.80 ± 0.35, n=15 neurons; 1-way ANOVA with Uncorrected Fisher’s LSD). *: 
p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are not significant unless otherwise stated. 
Behavioral data corroborate the above shown in vitro data. Quantification of mouse hind paw withdrawal 
threshold (force, g) after unilateral injection of hypotonic saline co-injected with vehicle (DMSO) or Apilimod 
(D). Reduction of withdrawal threshold of injected (ipsilateral, ipsi) paw compared to non-injected 
(contralateral, contra) paw indicates tactile allodynia i.e. lowered mechanical thresholds (N=10 animals per 
condition). Apilimod co-application significantly attenuates tactile allodynia (Hypotonic saline + DMSO 
ipsilateral; Hypotonic saline + Apilimod ipsilateral; N=10 animals per condition; *p<0.05, **p<0.01 black font; 
2-way ANOVA for repeated measures followed by Holm-Sidak’s multiple comparison test). Comparing 
corresponding ipsilateral versus contralateral paws within one condition (2-way ANOVA for repeated 
measures followed by Holm-Sidak’s multiple comparisons test; #p<0.05, ###p<0.001; Hypotonic + Vehicle, 
green colour; Hypotonic + Apilimod, red colour). All measurements were made in three time intervals 0-30 
minutes, 30-60 minutes and 60-90 minutes after injection.  
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Intracellular hypotonic shock rescues the increased Piezo2 currents seen upon Mtmr2 
knockdown 
Additional proof that PI(3,5)P2 is indeed a relevant factor for modulating RA-MA currents 
came from re-examining the Mtmr2 knockdown. Mtmr2 knockdown in DRG neurons 
would be expected to increase the cellular levels of PI(3,5)P2 as can be appreciated from 
the scheme in Figure 26A. From the literature and previous experiments it is known that 
osmotic stress can manipulate PI(3,5)P2 levels (McCartney et al., 2014a). 
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In lieu of these observations, I tested if the application of osmotic stress (intracellular 
hypotonicity, which would be expected to decrease PI(3,5)P2 levels) would cause reversal 
of the RA-MA phenotype observed upon Mtmr2 knockdown (Figure 24). Strikingly, the 
application of hypotonic intracellular solution to Mtmr2 knockdown neurons indeed 
reduces the RA-MA current magnitude compared to application of isotonic intracellular 
solution (2-way ANOVA followed by Holm-Sidak’s test; Figure 32A). Activation threshold 
of the RA-MA currents remained unchanged upon this treatment (Mann Whitney test; 
Figure 32B). This result reinforces the idea that PI(3,5)P2 plays an important part in the 
Mtmr2-Piezo2 interaction and may also be involved in direct modulation of Piezo2.   
Figure 32: Hypotonic intracellular stress rescues RA-MA potentiation upon loss of Mtmr2  
Stimulus-current curves of RA-MA currents in DRG neurons treated with Mtmr2 siRNA upon exposure to 
hypotonic extracellular stress (A). As shown in Figure 24, treatment of DRG neurons with Mtrm2 siRNA 
causes potentiation of Piezo2 RA-MA currents. Application of intracellular hypotonic stress to the Mtmr2 
siRNA treated neurons, caused a significant decrease in the potentiated RA-MA currents (Mtmr2 siRNA + 
isotonic intracellular solution: n= 30 neurons; Mtmr2 siRNA + hypotonic extracellular solution: n= 28 
neurons; 2-way ANOVA suggested a significant (P<0.0001) effect on the RA-MA currents. Holm-Sidak’s 
multiple comparison test was performed to compare both conditions at individual stimulus magnitude, p-
values are indicated on the graph with ‘*’). (B) Activation threshold of RA-MA currents was unchanged upon 
application of the hypotonic stress (Mtmr2 siRNA + isotonic intracellular solution: 4.00 ± 0.23 µm, n=26 
neurons; Mtmr2 siRNA + hypotonic intracellular solution: 4.68 ± 0.20µm, n=19 neurons; ns; Mann Whitney 
test). *: p<0.05; **: p<0.01; ***: p<0.0001; ****: p<0.00001; data are not significant unless otherwise stated. 
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4.5. Summary of part 2 
 Myotubularin related protein (Mtmr2) was identified as a high probability interactor of 
Piezo2 
 Co-expression of Piezo2 with Mtmr2 suppresses RA-MA (Piezo2) currents in HEK293 
cells.  
 Upon overexpression in DRG neurons, Mtmr2 suppresses native RA-MA currents.  
 Loss of Mtmr2 in DRG neurons potentiates Piezo2 mediated RA-MA currents 
specifically 
 Mtmr2 phosphatase activity is required for the modulation of RA-MA currents seen in 
HEK293 cells 
 PI(3,5)P2 ( and to a lesser extent PI(3)P) is involved in the modulation of Piezo2 
currents 
 Basic amino acid rich peptide sequences in Piezo2 and Mtmr2 can bind PI(3,5)P2 
 Hypotonic cellular stress potentiates Piezo2 through changes in cellular levels of 
PI(3,5)P2  
 Hypotonic stress induced mechanical allodynia in mouse paw, also mediated via 
changes in PI(3,5)P2 levels   
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5. DISCUSSION 
5.1. Relevance of studying Piezo2 protein complexes 
Piezo2 is the bona fide MA channel in mouse somatosensory neurons (Coste et al., 
2010; Coste et al., 2012). It is essential for light touch and proprioception in mouse 
(Florez-Paz et al., 2016; Ranade et al., 2014; Woo et al., 2015). There is also 
accumulating evidence for the role of Piezo2 in mechanical allodynia and hyperalgesia 
(Dubin et al., 2012; Eijkelkamp et al., 2013; Ferrari et al., 2015; Lolignier et al., 2014). 
Despite these advances in the understanding of Piezo2, the structure and regulation of 
the channel remains uncharacterized. Recent studies have explored the structure of 
Piezo1 (the other member of the mammalian Piezo family) (Coste et al., 2015; Ge et al., 
2015; Wu et al., 2016a) and an understanding of the Piezo2 structure may soon follow. 
Yet the regulation of the Piezo2 ion channel is hardly understood. Figure 4 illustrates the 
regulators/interactors of Piezo2 that have been identified so far. Stoml3 (Stomatin-like 
protein 3) directly interacts with Piezo2 and modulates its activity by influencing local 
membrane properties (Poole et al., 2014; Qi et al., 2015). Loss of Stoml3 in mice causes 
a reduction in the tactile discrimination performance and a loss of mechanical allodynia 
upon chronic constriction injury (Wetzel et al., 2007). Another known regulator of Piezo2 
is transcription factor, Runx1. Loss of Runx1 from a subset of somatosensory neurons 
causes a decrease in the number of Piezo2 positive small diameter neurons (Lou et al., 
2013). Besides this, CamKII and Kv1.1 are regulators of mouse somatosensory 
mechanotransduction which have not yet been shown to be directly linked to Piezo2 (Hao 
et al., 2013; Yu et al., 2015).  
Considering that the sense of touch is a combination of several modalities, it requires the 
components of the system to have a large and varied stimulus-response range. Some of 
these variations are generated by anatomical structures including the HTMRs and 
LTMRs (Abraira and Ginty, 2013), yet I believe that some of this variation must arise from 
the modulation of molecular components including Piezo2. Ion channels often exist as 
part of multi-protein complexes which are involved in their transport, regulation etc. 
(Levitan, 2006). Our group set out to identify if Piezo2 in somatosensory DRG neurons 
also exists as part of such a complex and used a mass-spectrometry based interactomics 
approach to identify potential components of said complex (Narayanan et al., 2016).   
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5.1.1. Identified proteins and possible relevance to Piezo2 function 
Through the screen we identified 36 potential interactors of Piezo2 in DRG neurons 
(Figure 6B; Narayanan et al. (2016)). These identified proteins are involved in protein 
transport, cellular localization, protein autophosphorylation, cell cycle regulation etc. 
Some of the proteins identified in the screen have already been implicated in 
somatosensation. Potassium channel subunits Kcna1 and Kcna2 were implicated in 
mechanotransduction. Interestingly, Kcna1 (Kv1.1) displays MA currents which regulates 
mechanical sensitivity of C-HTMRs and Aβ-mechanoreceptors (Hao et al., 2013). Another 
protein identified on the screen is the calmodulin-dependent protein kinase II (CamKII). 
CamKII is involved in calcium-mediated cell signaling and activity dependent changes in 
neurons (Hudmon and Schulman, 2002). CamKII has recently been implicated in the 
adaptation of low-threshold Aβ-mechanoreceptors (Yu et al., 2015). Whether these two 
proteins are direct modulators of Piezo2 remains to be studied.      
5.1.2. Challenges and limitations of this approach 
Our study in 2016 is the first to systematically identify the interactors of Piezo2 in mouse 
somatosensory neurons (Narayanan et al., 2016). Certain aspects of this study merit 
discussion. An important one is the use of the DRG tissue (where cell bodies of the DRG 
neurons lie) to identify the Piezo2 interactors. It is implicit that Piezo2 expressed in the 
peripheral tissue (e.g. skin) would be more ideal to study its role and regulation in fine 
touch. This was considered at the conceptualization of the study and various factors 
prompted the study to be carried out in the tissue containing the cell bodies. Firstly, 
technical difficulties make the study of protein complexes in peripheral nerve endings, 
complicated. The peripheral nerve endings are very sparsely located in tissues such as 
skin and further Piezo2 is only expressed in a subset of these nerve endings (Abraira and 
Ginty, 2013; Ranade et al., 2014; Woo et al., 2014). It would therefore be 
methodologically challenging to obtain enough material for an immunoprecipitation based 
analysis. Secondly, it is known that Piezo2 is expressed both peripheral nerve endings 
and DRG neurons (Coste et al., 2010; Ranade et al., 2014). Of note, Piezo2 was first 
identified as the MA channel in murine somatosensation, in the cells bodies of DRG 
neurons (Coste et al., 2010). Additionally several studies have shown that manipulating 
Piezo2 in sensory neuron cell bodies can affect Piezo2-mediated behaviors in vivo 
(Eijkelkamp et al., 2013; Ranade et al., 2014) indicating that properties of Piezo2 in the 
cell bodies are reflective of its role in tactile behavior. Therefore it is expected that the 
components required for the function of Piezo2 are present at both cell body and 
peripheral levels. Despite this, it cannot be ruled out that there may be interactors of 
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Piezo2 that may be specific to cell bodies or peripheral nerve endings. One way to 
address this issue, is to orthogonally validate the interactomics approach using in vitro 
functional studies and characterization of the identified interactors in vivo and study their 
role in regulating Piezo2 mediated behaviors. This can prove useful to discriminate 
between interactors that may be cell body specific and interactors that play a role in 
Piezo2 mediated behaviors. Therefore, an interactomics screen in the cell bodies has the 
potential to identify meaningful interactors of mechano-gated channel, Piezo2.  
Although our interactomics screen as mentioned in the last section was capable of 
identifying biologically significant interactors of Piezo2, it is important to note that the 
method has its limitations. Though the conditions of immunoprecipitation in DRG neurons 
were as close as biochemically possible to the in vivo situation, this approach may miss 
transient or weak interactions. Hence the list of interactors identified by us may not 
represent the complete interactome of Piezo2 (Narayanan et al., 2016). One key Piezo2 
interactor that we did not find on our screen was Stoml3. As has been mentioned several 
times in this study, Stoml3 modulates Piezo2 activity in DRG neurons and regulates 
Piezo2 mediated behaviors in mice (Poole et al., 2014; Qi et al., 2015; Wetzel et al., 
2007). There could be several reasons for the failure of our screen to identify Stoml3. 
Firstly, Stoml3 may transiently regulate Piezo2, making its identification through 
immunoprecipitation difficult. Furthermore, originally Piezo2-Stoml3 direct binding has 
only been seen in HEK293 cells (Poole et al., 2014). It is therefore possible that in DRG 
neurons the proteins do not interact directly but rather through other intermediates. 
Lastly, the cellular abundance or stoichiometry of proteins may play an important role in 
their identification through immunoprecipitation. This may explain the difference between 
an overexpression system like HEK293 cells and native system of DRG neurons. In 
conclusion, though the interactomics screen provides a robust resource for the 
exploration of Piezo2 regulation (Narayanan et al., 2016), it is important to keep in mind 
that this in no way represents the complete Piezo2 interactome.       
5.2. Identification of Pericentrin (Pcnt) as a Piezo2 interactor in DRG neurons 
After the identification of potential Piezo2 interactors, the first step was the orthogonal 
validation of the interactors to show that the screen indeed identified meaningful 
interactors of Piezo2. Of the identified components of the putative Piezo2 interactome, 
Pcnt came up as an unlikely interactor of Piezo2. It is a protein known for its role in cell 
cycle regulation and organization of the microtubule organizing complex (MTOC) and has 
not been extensively studied in the context of sensory systems (Delaval and Doxsey, 
2010). Pcnt was chosen for the orthogonal validation of the screen for two reasons; 
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firstly, considering it was an unlikely interactor of Piezo2, a validation of its interaction 
with Piezo2 would highlight the robustness of our interactomics screen; and secondly, a 
study in Drosophila showed that loss of Pcnt homolog (d-PLP) in flies caused 
mechanosensory deficits in the fly (Martinez-Campos et al., 2004). This indicated a 
possible link for Pcnt to somatosensory mechanotransduction. Based on these factors I 
proceeded to characterize the role of Pcnt in Piezo2 function.  
The data obtained in this study indicate that Piezo2 and Pcnt are expressed in close 
apposition in the somatosensory endings in the skin and in DRG neuron cell bodies. The 
identification of Pcnt in the somatosensory endings came as a surprise, since Pcnt has 
never been reported in similar structures and its described roles so far do not anticipate 
such localization (Delaval and Doxsey, 2010). Due to limitations of experimental 
techniques we could not study this localization in more detail (Narayanan et al., 2016). 
Therefore the function of this close apposition of Pcnt with Piezo2 in the nerve endings 
remains unknown. It would be interesting to use high resolution microscopy to gain a 
better understanding of these peripheral endings. It is relevant to note here that the 
cutaneous endings (LTMRs) are engulfed by terminal Schwann cells (Li et al., 2011; 
Shenton et al., 2014). It therefore cannot be excluded that the Pcnt immunolabel seen in 
these structures arises in the Schwann cells (as is also hinted from our own data showing 
apposition of Pcnt immunolabel with Schwann cell marker, S100). Interestingly, Schwann 
cells have been shown to form cellular junctions with the terminal endings which could be 
relevant for cellular cross-talk or regulation (Kaidoh and Inoué, 2000). Hence, if the Pcnt 
localized to the Schwann cells could still be a regulator of neuronal properties.       
In the cell bodies of DRG neurons, loss of Pcnt potentiates Piezo2 RA-MA currents with 
remarkable specificity. In addition I also found the level of membrane Piezo2 was 
increased upon loss of Pcnt. An increase in the number of Piezo2 channels on the 
membrane could explain the increased magnitude of MA currents. It remains to be seen 
how Pcnt contributes to increase in membrane expression of the channel.  
Interestingly, Pcnt besides its role in cell cycle regulation is also known to be part of the 
microtubule organizing complex (MTOC) (Chen et al., 2004; Doxsey et al., 1994). Based 
on this knowledge, regulation of microtubule based transport of Piezo2 to the membrane 
was explored as a potential mechanism for Piezo2-Pcnt interaction. Contrary to 
expectations, Nocodazole, an inhibitor of microtubule stability did not affect Piezo2 
mediated currents (Dammermann, 2002). This could be either because Piezo2 transport 
to the plasma membrane is not mediated by microtubules or could hint to multiple 
mechanism for Piezo2 transport which could have compensatory functions. It is known 
that stability of actin cytoskeleton plays a crucial role in Piezo2 function (Jia et al., 2016). 
Whether it has a role in localization of Piezo2 to plasma membrane remains to be tested.  
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Notably, the role of cytoplasmic Pcnt has not been elucidated so far. As we and others 
have observed (Chen et al., 2014; Jurczyk et al., 2010; Miyoshi et al., 2009; Mühlhans 
and Gießl, 2012; Narayanan et al., 2016), besides its centrosomal and MTOC 
localization, Pcnt is also expressed in the cytoplasm in certain cell types. According to 
immunostaining data (Figure 13B and C), nucleofection of DRG neurons with Pcnt 
siRNA, decreases Pcnt expression in both the centrosomal and cytoplasm. Therefore it is 
possible that the potentiation of Piezo2 currents seen here could be due to loss of 
cytoplasmic Pcnt.  
Interestingly, one study found Pcnt enriched in the secretory vesicles in the cytoplasm of 
pancreatic β-cells. RNAi mediated knockdown of Pcnt in these cells resulted in 
hypersecretion of these vesicles (Jurczyk et al., 2010). This result presents the idea that 
cytoplasmic Pcnt may be involved in regulation of secretory vesicles and thereby Piezo2 
localization to the plasma membrane. This hypothesis can be tested by treating Pcnt 
knockdown DRG neurons with inhibitors of exocytosis. If loss of Pcnt indeed dysregulates 
vesicle exocytosis, the inhibitor would be expected to rescue the effect. 
Of note, our interactomics screen also identified pericentriolar material 1 (PCM1), an 
already known interactor of Pcnt (Dammermann, 2002; Li et al., 2001). It is therefore 
possible that Pcnt and PCM1 form a complex that controls Piezo2 function. It would be 
interesting to explore this multi-protein interaction and its relevance to Piezo2 function.  
In order to characterize the Piezo2-Pcnt interaction and understand its mechanism, a 
somatosensory system specific inducible knockdown of Pcnt would be a valuable tool. It 
is important to note here that due to the role of Pcnt in cell cycle regulation, a systemic 
knockdown of Pcnt is prenatally lethal (Chen et al., 2014). Therefore a knockdown 
specific to the somatosensory neurons would help analyze the relevance of Pcnt in 
Piezo2 mediated behaviors in vivo.  
Nonetheless, identification of Pcnt as a meaningful interactor of Piezo2 in DRG neurons 
reinforces the validity of our interactomics approach and opens the possibilities of 
characterizing several meaningful modulators of Piezo2 function.  
5.3. Identification of Mtmr2 as a Piezo2 interactor in DRG neurons 
Through the immunoprecipitation based interactomics approach several interactors of 
Piezo2 were identified by our group (Narayanan et al., 2016). Among the identified 
proteins, we found three members of a family of phosphatases namely, Mtmr1, Mtmr2 
and Mtmr5 (Sbf1). These proteins are members of the myotubularin phosphatase family 
that are involved in dephosphorylating phosphatidylinositols at the 3-phosphate position 
(Bolis et al., 2007). Of these, Mtmr2 has been strongly linked to the somatosensory 
system in lieu of its role in the peripheral neuropathy CMT4B1 (Bolino et al., 2004; Bolis 
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et al., 2005; Previtali et al., 2007). Patients with CMT4B1, display severe sensory deficits 
in the distal limbs with pronounced effect on the sense of vibration (Previtali et al., 2007). 
Intriguingly, patients with loss of function mutations in Piezo2 also show general losses in 
vibration detection besides loss in discriminatory touch (Chesler et al., 2016).  
The other two phosphatases, Mtmr1 and Mtmr5, identified in our screen were also high 
probability Piezo2 interactors. Mtmr1, despite being the first identified member of the 
MTMR family, has not been studied extensively. It displays similar structural features and 
substrate specificity as Mtmr2 (Bong et al., 2016). And, Mtmr5 is an enzymatically 
inactive member of the MTMR family and is known to bind to Mtmr2 and increase its 
enzymatic activity and dictate its subcellular localization (Kim et al., 2003).  
Based on available evidence and defined expression in the somatosensory system, I 
proceeded to characterize Mtmr2 as a potential functional interactor of Piezo2 in DRG 
neurons. As shown in the results section (section 4.2), I found that loss of Mtmr2 from 
DRG neurons selectively potentiates Piezo2 mediated RA-MA currents. Concomitantly, 
overexpression of Mtmr2 in DRG neurons and HEK293 cells suppresses the endogenous 
or overexpressed Piezo2 RA-MA currents, respectively. Additionally, the catalytic activity 
of Mtmr2 was found to be essential for its regulation of Piezo2 mediated RA-MA currents. 
Of note, another member of the MTMR family, Mtmr6 was shown to inhibit KCa3.1 
potassium channel activity, through depletion of PI(3)P (Srivastava et al., 2005). 
Therefore it is not entirely unprecedented that Mtmr phosphatases regulate ion channel 
function.  
Remarkably, probing further into the mechanism of Mtmr2-Piezo2 interaction showed that 
PI(3,5)P2 may be involved in the interaction. As shown in Figure 8B, Mtmr2 uses PI(3)P 
and PI(3,5)P2 (the latter preferentially; Berger et al. (2002)) as substrates. An inhibition of 
Mtmr2 would be expected to increase both PI(3,5)P2 and PI(3)P. I used two approaches 
to counteract this increase of PI(3,5)P2 upon Mtmr2 knockdown. Apilimod application, to 
block synthesis of PI(3,5)P2 (scheme in Figure 27A) and hypotonic intracellular stress to 
decrease PI(3,5)P2 levels. Apilimod is a specific blocker of the PI(3,5)P2 synthesizing 
enzyme PIKfyve (Vaccari et al., 2011). Its application reverses the Piezo2 potentiation 
seen upon Mtmr2 knockdown. I also tested the possibility of PI(3)P being involved in the 
modulation of Piezo2 using Wortmannin an inhibitor of the class III PI 3-Kinase which 
synthesizes PI(3)P (Figure 27A) (Messenger et al., 2015). These experiments showed 
that Wortmannin application had a much smaller effect on Piezo2 RA-MA currents 
compared to Apilimod treatment. This could be due to a smaller contribution of PI(3)P 
(compared to PI(3,5)P2) to the Piezo2 potentiation. However, Wortmannin activity is 
known to be rather unspecific and it is known to also block the class I PI 3-kinase which 
is involved in the synthesis of PI(3,4,5)P3 from PI(4,5)P2 (Messenger et al., 2015). Hence 
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(i) Wortmannin could have lower efficiency towards class III PI 3-kinase in our system 
(Messenger et al., 2015) or (ii) its modulation of the PI(4,5)P2 pathway may influence the 
RA-MA currents. It is relevant to note here that activation of TRPV1 suppresses RA-MA 
currents by depletion of PI(4,5)P2. Hence, Wortmannin which would be expected to 
increase PI(4,5)P2 levels (Messenger et al., 2015) could cause a potentiation of Piezo2 
through this alternative pathway thereby confounding the study of PI(3)P effect on Piezo2 
RA-MA currents. Though these data prove inconclusive in elucidating the role for PI(3)P 
in the regulation of Piezo2, they provide interesting hints towards cross-talk between 
membrane lipids in regulation of Piezo2. Notwithstanding, the Apilimod data strongly 
indicate a role for PI(3,5)P2 in the interaction between Piezo2 and Mtmr2. In order to test 
this using another method, I exploited the fact the PI(3,5)P2 levels are transiently but 
robustly modulated in response to osmotic stress (Previtali et al., 2007). Osmotic stress 
applied intracellularly to decrease levels of PI(3,5)P2 was able to counteract the Piezo2 
RA-MA potentiation caused by the loss of Mtmr2. Both these approaches indicate that 
PI(3,5)P2 (and to a yet unknown extent PI(3)P) may play a role in the Piezo2 and Mtmr2 
interaction.  
Additional evidence that Piezo2, Mtmr2 and PI(3,5)P2 interact on a cellular level came 
from biochemical binding assays. I found evidence to indicate that Piezo2 can bind 
directly to PI(3,5)P2. I identified a poly-basic intracellular peptide sequence in the Piezo2 
structure which could bind PI(3,5)P2 in vitro. Interestingly, the same Piezo2 fragment was 
also able to bind an Mtmr2 PI(3,5)P2-binding peptide. The Piezo2-Mtmr2 binding 
appeared to be independent of the presence or absence of PI(3,5)P2. Further, the binding 
of the Piezo2 peptide to PI(3,5)P2 and Mtmr2 peptide was dependent on the basic amino 
acids in the sequence as shown by the inability of the mutant 3Q peptide to bind 
PI(3,5)P2. The data hint towards a potential tripartite interaction between Piezo2, Mtmr2 
and PI(3,5)P2 mediated by charged amino acids.  
The next question was if PI(3,5)P2 can independently regulate Piezo2. Towards this goal 
Apilimod was applied to untreated DRG neurons and RA-MA currents measured. 
Curiously RA-MA currents remained unaffected, which could be explained by the low 
baseline expression of PI(3,5)P2 in cells. Therefore under physiological conditions, 
decreasing PI(3,5)P2 may not have a cellular consequence. Additionally I also tried to 
artificially increase the levels of cellular PI(3,5)P2 by addition of synthetic diC8 PI(3,5)P2 
to DRG neurons. No effect on RA-MA currents was observed even at saturating 
concentrations of PI(3,5)P2. This could be explained either by mis-localization of 
synthetics PIPs in the cells or because of a fast turnover of PI(3,5)P2 through the action 
of cellular phosphatases.  
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However, paradigms involving application of osmotic stress to DRG neurons provides 
evidence for a direct regulation of Piezo2 mediated currents and behavior by PI(3,5)P2. 
As described earlier, subjecting cells to osmotic stress regulates levels of PI(3,5)P2 
transiently and drastically. Additionally, osmotic stress was also shown to potentiate 
Piezo2 mediated currents and behaviors (as seen from our own data Figure 31 and 
previously published data from Jia and colleagues (Jia et al., 2016)). Interestingly, upon 
application of PIKfyve blocker Apilimod, to neurons subjected to osmotic stress, the 
potentiation of Piezo2 currents can be reversed. Furthermore osmotic stress induced 
mechanical allodynia in mouse paw can be reversed by application of Apilimod. These 
data point to a direct regulation of the Piezo2 channel by PI(3,5)P2.   
There are several possibilities of how PI(3,5)P2 and Mtmr2 may regulate Piezo2. Mtmr2 
may bind Piezo2 to facilitate its enrichment in PI(3,5)P2 rich micro domains within the 
plasma membrane. A schematic of this hypothesis is illustrated in Figure 33. In the 
proposed mechanism Mtmr2 binds to Piezo2 at the plasma membrane and under normal 
conditions, limits the amount of PI(3,5)P2 by catalyzing its rapid turnover. Loss of Mtmr2 
(through Mtmr2 siRNA) causes an increase in the local PI(3,5)P2. This increased 
PI(3,5)P2 potentiates Piezo2 currents through a yet unknown mechanism. On the other 
hand, an increase in cellular Mtmr2 (through Mtrm2 overexpression) causes increased 
turnover of PI(3,5)P2 levels decreasing it below baseline. This causes a suppression of 
the Piezo2 activity. 
A highly speculative scenario for this potentiation is that the electrostatic binding of 
Piezo2 to the excessive PI(3,5)P2 causes structural changes in the channel causing an 
increase in the channel activity. A similar regulation is seen with TRPML1 where it was 
proposed that PI(3,5)P2  sensitizes TRPML1 making it easier to activate (Dong et al., 
2010; Shen et al., 2011). A comparable process may operate during PI(3,5)P2 regulation 
of Piezo2, though in order to study this, a detailed understanding of the Piezo2 structure 
and the mechanism of its conduction would be required. Another possibility is that 
PI(3,5)P2 acts as a secondary messenger and initiates downstream signaling cascades 
which influence Piezo2 function. The PI(4,5)P2 mediated regulation of Piezo2 upon 
TRPV1 activation relies on such a pathway (Borbiro et al., 2015).  
In order to study the Piezo2-Mtmr2-PI(3,5)P2 interaction further, we need tools to faithfully 
visualize the proteins in the native system and how they may re-distribute/re-arrange 
upon application of stimuli. Though there are fluorescent probes that can detect 
membrane lipids in native cells, none of them have been shown to be useful for the 
detection of PI(3,5)P2 (Hammond et al., 2015; Li et al., 2013). The extremely low cellular 
abundance of PI(3,5)P2 poses a challenge to explore its role under physiological 
conditions. Furthermore, there are two Mtmr2 knockout mice used commonly in the field 
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as models for CMT4B1 (Bolino et al., 2004; Bonneick et al., 2005). We unfortunately did 
not have access to these mice for this study, but a somatosensory characterization of 
these mice could provide interesting hints towards the role of Mtmr2 in Piezo2 mediated 
behaviors. Also, whether Mtmr2-Piezo2 interaction has a role to play in the peripheral 
neuropathy (CMT4B1) could be answered through experiments with these mice.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33: Illustration of Piezo2-PI(3,5)P2-Mtmr2 interaction  
Under normal conditions Mtmr2 binds to Piezo2 and maintains it close to the local PI(3,5)P2  membrane 
pools. Under these conditions, Mtmr2 maintains the amount of PI(3,5)P2 by regulating its turnover. Loss of 
Mtmr2 (through Mtmr2 siRNA) leads to an increase in the local levels of PI(3,5)P2 leading to a potentiation of 
Piezo2 (possibly through structural changes in Piezo2). Further, overexpression of Mtmr2 in the cells causes 
increased turnover of PI(3,5)P2, decreasing it cellular availability. This leads to a suppression of the Piezo2 
mediated RA-MA currents. How PI(3,5)P2 availability regulates the Piezo2 function remains to be seen, it 
could be speculated that either structural changes in Piezo2 or action of secondary messenger mediated 
signaling cascades could play a role.   
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5.4. Piezo2 function is controlled by a defined set of interacting proteins 
In this study I characterized two interactors of Piezo2 in somatosensory neurons. Both 
proteins were identified through a mass-spectrometry based interactomics approach. The 
immunoprecipitation was done using the commercial Piezo2 antibody (NBP1-78624; 
Narayanan et al. (2016)) which was tested to reliably detect Piezo2 in mass-spectrometry 
experiments (Narayanan et al., 2016).  
In 2014, Woo and colleagues reported the generation of an anti-Piezo2 antibody, which 
showed specificity on tissue from Piezo2GFP and skin-specific Piezo2 knockout mice (Woo 
et al., 2014). Using this antibody, we performed an additional immunoprecipitation based 
mass-spectrometry screen (Performed by Dr. Tom Rouwette and Julia Sondermann, 
Somatosensory Signaling and Systems Biology group). Surprisingly we found a distinct 
set of interactors using this antibody. (Of note, this experiment was only repeated twice 
and complete statistics could not be performed). Yet the difference in the list of proteins 
identified is surprising. There may be various explanations for the differences we 
observed. First, the two antibodies differ in the region of Piezo2 they bind (Antigenic 
peptide for NBP1-78624; Novus Biologicals) corresponds to the 1600-1650 amino acids 
region, close to C-term of Piezo2; Antigenic peptide for anti-Piezo2 antibody from Woo 
and colleagues corresponds to 351-485 amino acid peptide, close to the N-term of the 
protein). This could affect the secondary structure of the protein and thereby influence the 
binding properties. Additionally, depending on the strength of anti-Piezo2 antibody 
binding to Piezo2, it could also influence the binding properties of the interacting partners. 
Therefore, identification of weak or transient interactors may vary depending on the 
strength of the anti-Piezo2 antibody.  
Due to the significant differences in the protein lists, I tested if the proteins identified on 
the new screen also constituted bona fide Piezo2 interactors. For this purpose, two 
proteins namely; MAP7 domain containing protein (MAP7d2) and Lunapark (Lnp) were 
chosen. MAP7d2 was identified as a X-linked maternal imprinted gene in humans which 
is expressed highly in the brain (Niida and Yachie, 2011). Though there have not been 
many studies on MAP7d2, recently Tymanskyj and colleagues showed the MAP7 
regulates the development of axon collateral branches in DRG neurons. These axon 
collaterals are essential for DRG neurons to form multiple synaptic connections 
(Tymanskyj et al., 2017).  Lunapark was identified in 2003 by Spitz and colleagues in the 
developing digits with similar profile as development related Hox genes (Spitz et al., 
2003). It was later shown to be required for ER network formation. Structurally, Lnp 
contains two transmembrane domains and a zinc finger motif (Chen et al., 2013).  Both 
proteins are newly discovered and there is not much information on their cellular function 
and no roles have been described in the context of somatosensation. As a preliminary 
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analysis, I tested if suppression of these proteins in DRG neurons would impact Piezo2 
mediated RA-MA currents. Surprisingly I did not observe any impact on the Piezo2 
mediated currents upon loss of either of the proteins (data not shown). This could be 
because the tested proteins may simply be part of a complex modulating Piezo2 and 
there may be other cellular components with compensatory functions. The lack of 
functional interaction could also mean that the new anti-Piezo2 antibody could not 
robustly identify Piezo2 interactors. Nevertheless, these experiments do demonstrate that 
not all proteins expressed in DRG neurons can influence Piezo2 function. Combining this 
with the functional data reporting interaction of Piezo2 with Pcnt and Mtmr2, it underlines 
the fact that there is indeed a defined complex of proteins that regulate Piezo2 function in 
vitro. The lack of consensus between the two mass spectrometry screens also highlights 
the need to study the Piezo2 interactors through multiple approaches. Complementary 
methods to identify interactors of Piezo2 could include bioinformatics approaches based 
on genomic information or protein structures, genomic approaches like yeast two-hybrid 
screening and biochemical approaches using cross-linking of associated proteins prior to 
co-immunoprecipitation (Ivanov et al., 2011). Further orthogonal validation of the 
interactions is essential to establish proteins as bona fide interactors of Piezo2 in vitro 
and in vivo.   
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Supplementary tables 
Table 1: Details of plasmids used in this study 
plasmid name source 
pCMVSport6-Piezo2-GST IRES GFP Kind gift from Prof. Ardem Patapoutian 
pCMV6-Mtmr2-myc-DDK Origene 
pCMV6-Mtmr2 C417S-myc-DDK Self-generated 
pCMVSport6-Pericentrin Self-generated 
pCMVSport6 Kind gift from Prof. Ardem Patapoutian 
pCDNA-Piezo1-IRES-myc Kind gift from Prof. Ardem Patapoutian 
pCDNA3.1-myc-His Invitrogen 
pGEM-T easy-Kv 1.1-HA Source not available 
pCDNA3-GST Kind gift from Prof. Ardem Patapoutian 
Table 2: Details of antibodies used in this study 
antibody 
source, catalogue 
number 
application dilution 
Chicken anti-GFP 
Life Technologies, 
A10262 
Immunohistochemistry, 
Immunocytochemistry 
1:500 
Mouse anti-FLAG Sigma Aldrich, F1804 Immunoblotting 1:500 
Mouse anti-myc Santa Cruz, sc-47694 
Immunocytochemistry, 
Immunoblotting 
1:100 
1:100 
Mouse anti-Tuj-488 
HISS Diagnostics, A488-
435L 
Immunohistochemistry 1:500 
Mouse anti-S100 Chemicon, MAB079-1 Immunohistochemistry 1:100 
Rabbit anti-GST Santa Cruz, sc-459 
Immunocytochemistry, 
Immunoblotting,  
1:500 
1:100 
Rabbit anti-mtmr2 Biotechne, NBP1-33724 Immunohistochemistry 1:500 
Rabbit anti-Pcnt Abcam, ab4448 
Immunohistochemistry, 
Immunocytochemistry 
1:500 
1:500 
Rabbit anti-Pcnt 
Biolegend (Covance), 
923701 
Immunohistochemistry, 
Immunocytochemistry, 
Immunoblotting 
1:750 
1:750 
1:1000 
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Rabbit anti-Piezo2 
Novus Biologicals, 
NBP1-785324SS 
Immunohistochemistry 1:200 
Rabbit anti-Piezo2 
Novus Biologicals, 
NBP1-785338SS 
Immunohistochemistry 1:200 
WGA-555 
Thermo Fisher Scientific, 
W32464 
Immunocytochemistry 1:200 
Alexa Fluor 488 Life Technologies 
Immunocytochemistry, 
Immunohistochemistry 
1:250 
Alexa Fluor 564 Life Technologies 
Immunocytochemistry, 
Immunohistochemistry 
1:250 
Alexa Fluor 555 Life Technologies 
Immunocytochemistry, 
Immunohistochemistry 
1:250 
Alexa Fluor 647 Life Technologies 
Immunocytochemistry, 
Immunohistochemistry 
1:250 
Alexa Fluor 680 Life Technologies Immunoblotting 1:8000 
IRDye 800CW Li-COR Immunoblotting 1:8000 
Duolink insitu PLA 
probe anti-rabbit 
MINUS 
Sigma-Aldrich 
PLA 1:10 
Duolink insitu PLA 
probe anti-mouse 
PLUS 
Sigma-Aldrich 
PLA 1:10 
AffinityPure Fab 
Fragment Donkey 
Jackson 
ImmunoResearch 
Immunohistochemistry 0.1 mg/mL 
Table 3: Details of siRNA used in this study 
siRNA  Company  Sequence 
SiGENOME Mouse Pcnt (18541) 
siRNA-SMARTpool  
Thermo scientific CAACAGAGAGGAACUGAAU 
GGUCCCAGCUUGAGUCUAU 
GAGAAACUGUCCAUAAUCA 
GAGAUUAGCCUCCAUGUUU 
 
GeneSolution siRNA (Cat No. 
1027416) 
Mm_Mtmr2 
Qiagen TGAGATTATTATGGCATAGTA 
CTGTTACTCTACTTTATCTAA 
GAGGCTTGTGTCAGATCCAAA 
CAGCTGGAAGACTTTACTAAT 
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siGENOME Mouse Lnp (69605) 
siRNA- SMARTpool 
Dharmacon GAACAGGUACGCCCUCAUA 
CAAGUCACCUGUUCUCAGA 
CUGUUUACCUGUUUAAUUG 
UGGCAUGGCUUUGAAGGAA 
siGENOME Mouse Map/d2 
(78283) siRNA- SMARTpool 
Dharmacon GAGGAAAGGCUGCGCAUAG 
GAGCCAAGCUUCAGUAUGA 
CAACAUCAACCAUGAAUUU 
GCGCAUGGCUGACAAGUAU 
ON-TARGETplus Non-targeting 
siRNA#1 
Dharmacon UGGUUUACAUGUCGACUAA 
AllStars Negative Control siRNA  
(Cat no. 1027280) 
Qiagen Not available 
Table 4: Details of primers used in this study 
Primer name Primer sequence (5’-3’) 
GAPDH_forward CAATGAATACGGCTACAGCAAC 
GAPDH_reverse TTACTCCTTGGAGGCCATGT 
Actin_forward GATCAAGATCATTGCTCCTCCTG 
Actin_reverse CAGCTCAGTAACAGTCCGCC 
Piezo2_forward AGGCAGCACATAGGATGGAT 
Piezo2_reverse GCAGGGTCGCTTCAGTGTA 
Pericentrin_forward CAAGGAGCACACCAGCAAGA 
Pericentrin_reverse CGTCCACACACTACGCAAGACT 
Mtmr2_forward TGTACCCCACCATTGAAGAAA 
Mtmr2_reverse TAAGAGCCCCTGCAAGAATG 
Lunapark_forward GTGCTCTGGATAGAATTGTTGAATAC 
Lunapark_reverse TGCTGACATATGAGGGCGTA 
Map7d2_forward TTTGGACACAGGGACCACTAC 
Map7d2_reverse TCATGGTTGATGTTGAAAGTTTG 
Mtmr2 mutagenesis primer_forward GTGGTACACTCCAGTGATGGATG 
Mtmr2 mutagenesis primer_reverse CACAGACGTCTTCCCAGA 
Pericentrin EcorV primer AGCGATATCATGGAAGACGAGCAGGAG 
Pericentrin Spe1 primer GCAACTAGTTCACTGTTTAATCTTCTGGTGG 
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Table 5: Details of peptides used in this study 
Peptide name Company  Peptide sequence 
Piezo2 peptide-FLAG tagged GenScript EWWRKILKYFWMSVVIDYKDDDDKQNN 
Mtmr2 peptide-myc tagged GenScript VASFRSRGRIPVLSEQKLISEEDLQNN 
Piezo2 3Q peptide- FLAG 
tagged 
GenScript EWWQQILQYFWMSVVIDYKDDDDKQNN 
Piezo2 X- FLAG tagged GenScript LWMIRNRRKYAMISSPDYKDDDDKQNN 
TRPA1 peptide  Alamone 
labs 
NSTGIINETSDHSE 
TRPV1 peptide Alamone 
labs 
EDAEVFKDSMVPGEK 
Table 6: Details of reagents used in this study 
Product Company 
10X PBS (Phosphate-buffered saline) pH 7.4 Life Technologies 
Agarose Roth 
Apilimod Cayman chemicals 
ATP (adenosine 5’-triphosphate) magnesium salt Sigma-Aldrich 
Bluejuice loading buffer 10X Life Technologies 
BSA (Bovine serum albumin) Sigma-Aldrich 
CaCl2 Roth 
Collagenase Worthington 
Complete ULTRA protease inhibitor cocktail tablets Roche 
CsCl Sigma-Aldrich 
DDM (Dodecyl-ß-D-maltoside) Roth 
DMEM (Dulbecco’s modified eagle medium), GlutaMAX Life Technologies 
DMEM (Dulbecco’s modified eagle medium)/F-12, 
GlutaMAX 
Life Technologies 
DMSO (dimethyl sulfoxide) Sigma-Aldrich 
Donkey serum Dianova 
Dosium deoxycholate Roth 
DTT (1,4- Dithiol-dl-threit-Isg.) Sigma-Aldrich 
Duolink insitu detection reagents orange Sigma-Aldrich 
Duolink insito probemaker plus Sigma-Aldrich 
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DTT (Dl- Dithiothretol) Sigma-Aldrich 
Dynabeads Protein G Life Technologies 
EDTA (ethylenediaminetetraaacetic acid) Roth 
EGTA (ethylene glycol tetraacetic acid) Roth 
FBS (Fetal bovine serum) Life Technologies 
FugeneHD transfection reagent Promega 
Glucose Roth 
Glutathione Thermo Science 
Glycerol Roth 
Goat serum Dianova 
Growth factors (NGF, GDNF, BDNF, NT-3, NT-4) R&D Systems 
GTP (guanosine 3’-triphosphate) sodium salt Sigma-Aldrich 
HEPES (4-2-hydroxyethyl)-1-piperazineethanesulfonic 
acid) 
Life Technologies 
Horse serum Life Technologies 
KCl Roth 
Laminin Life Technologies 
Library Efficiency DH5α Competent Cells ThermoFisher Scientific 
MgCl2 Roth 
Milk powder Roth 
NaCl Roth 
NaOH Roth 
Nitrocellulose Pre-Cut Blotting Membranes, 0.45µm 
pore size 
Thermo Fisher Scientific 
Nocodazole Sigma-Aldrich 
NucleoSpin RNA extraction kit Macherey Nagel 
NuPAGE blotting kit Life Technologies 
NuPAGE 3-8% Tris-Acetate Protein Gels Thermo Fisher Scientific 
OCT (optimal cutting temperature) compound Sakura 
OneTaq One-Step RT-PCR Kit New England Biolabs 
OPTIMEM medium Life Technologies 
Papain Worthington 
Penicillin/Streptomycin Life Technologies 
PFA (paraformaldehyde) Science services 
PI(3,5)P2 Echelon  
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PI(3)P Echelon 
Pierce Glutathione Magnetic beads Thermo Science 
PIP Strips Echelon 
Poly-D-Lysine Milipore 
Power SYBR green PCR master mix Life Technologies 
Q5 Site-directed mutagenesis kit New England Biolabs 
QuantiTech Rev. Transcription Kit Qiagen 
RPMI (Roswell Park Memorial Institute) medium Life Technologies 
Slowfade Gold antifade reagent with DAPI Life Technologies 
Sucrose Merck 
Tris-acetate gel (3-8%) Thermo Fisher Scientific 
Tris-HCl Roth 
Triton X-100 Roth 
Tween 20 Roth 
Wortmannin Sigma-Aldrich 
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Table 7: List of abbreviations 
AMPA α-amino-3-hydroxy-5methyl-4isoxazolepropionic acid 
AMPAR α-amino-3-hydroxy-5methyl-4isoxazolepropionic acid receptor 
ANOVA Analysis of Variance 
AU Arbitrary units 
BDNF Brain-derived neurotrophic factor 
Camk11 Ca
2+
/calmodulin-dependent protein kinase type II 
CED C-terminal extracellular domain 
CLSM Confocal laser scanning microscopy 
CMT4B1 Charcot-Marie-Tooth disease Type 4B1 
CTL C-terminal loop 
CTRL Control 
DEG/ENaC Degenerin/epithelial sodium channel 
DIV Days in vitro 
DNA Deoxyribonucleic acid 
DRG Dorsal root ganglion 
EM Electron microscopy 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GDNF Glial cell line-derived neurotrophic factor 
GFP Green fluorescent protein 
GO Gene ontology 
GST Glutathione S-transferase 
HEK Human embryonic kidney cells 
HTMR High threshold mechanoreceptor 
IA-MA Intermediately adapting mechanically activated current 
IP Immunoprecipitation 
IRES Internal ribosome entry site 
kDa Kilo Dalton 
LC-MS/MS Liquid chromatography-mass-spectrometry 
LTMR Low threshold mechanoreceptor 
MA Mechanically activated 
MS Mass spectrometry 
MscL Mechanosensitive channel of large conductance 
MscS Mechanosensitive channel of small conductance 
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Mtmr Myotubularin-related protein 
MTOC Microtubule organizing complex 
NCBI National Center for Biotechnology information 
NF-200 Neurofilament 200 
NGF Nerve growth factor 
Nomp No mechanoreceptor potential 
NT-3 Neurotrophin-3 
NT-4 Neurotrophin-4 
PC Polycystin channel 
PCM Pericentriolar material 
Pcnt Pericentrin 
PCR Polymerase chain reaction 
PI Phosphatidylinositol 
PI(3,5)P2 Phosphatidylinositol 3,5-bisphosphate 
PI(4,5)P2 Phosphatidylinositol 4,5-bisphosphate 
PI3P Phosphatidylinositol 3-phosphate 
PIP Phosphatidylinositol phosphate 
PLA Proximity ligation assay 
RA-MA Rapidly adapting mechanically activated current 
RNA Ribonucleic acid 
SA-MA Slowly adapting mechanically activated current 
SEM Standard error of mean 
Stoml3 Stomatin-like protein-3 
TG Trigeminal ganglion 
TH Tyrosine hydroxylase 
TMC Transmembrane channel 
TMHS  Tetra-span membrane protein of hair cell stereocilia 
TMIE Transmembrane inner ear expressed gene 
TRP Transient receptor potential 
VGLUT Vesicular glutamate transport 
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